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Mitochondrial respiratory capacity and oxidative stress have been implicated in 
the development of insulin resistance (IR) and type II diabetes. A causative role of 
mitochondrial oxidative stress in the etiology of diet-induced IR has been suggested. 
Metabolic oversupply causes mitochondrial oxidative stress and leads to IR; however, 
how the other side of the metabolic balance equation, energy expenditure, may 
compensate for oversupply is less appreciated. Based on the principles of bioenergetics, 
in the condition of substrate oversupply without sufficient energy expenditure, the 
mitochondrial membrane potential (ΔΨm) is high and an exponential increase in 
superoxide generation occurs within a small range of ΔΨm exceeding about -160mV. 
The inverse occurs when the mitochondrial energy expenditure rises. In this context, it 
II 
 
was hypothesized that a mild increase in energy expenditure can sufficiently attenuate 
the over-nutrition caused H2O2 emission and IR. 
To examine this hypothesis acutely, Sprague-Dawley (S-D) rats received a lipid 
oral gavage with or without 1h of subsequent low intensity exercise. Mitochondria of 
permeabilized skeletal muscle fibers were studied. The results show that, without a 
change in respiratory capacity, a single lipid loading quickly elevated ΔΨm, 
mitochondrial H2O2 emitting potential (mEH2O2) and reduced calcium retention capacity 
(an index of the resistance of mitochondrial permeability transition) in state IV and/or 
under ―clamped‖ physiological state III respiration conditions. These effects can be 
quickly and sufficiently attenuated by a single bout of postprandial low intensity exercise. 
These findings provide evidence that mitochondrial H2O2 production/emission and 
related effects, but not respiratory capacity, are acutely and dynamically regulated by 
the metabolic status of skeletal muscle. 
Further, to examine this hypothesis chronically, S-D rats were high fat diet (HFD, 
60%) fed for 7 weeks with or without either low intensity exercise or 
β-guanidinopropionic acid (β-GPA), which chronically elevates mitochondrial energy 
turnover. The results show that HFD decreased insulin action and increased mEH2O2, 
whereas both were preserved by either exercise or β-GPA. The treatment effects of 
HFD, exercise or β-GPA were mitochondrial respiratory function and fatty acid oxidation 
rate independent. However, 5‘-AMP-activated protein kinase (AMPK) activity, an energy 
sensing kinase that increases glucose uptake, was also increased by β-GPA treatment. 
To determine whether AMPK mediated the β-GPA-induced improvements in insulin 
action, skeletal and cardiac muscle-specific AMPK α2 catalytic subunit dominant 
negative mutated (non-functional) mice and their wild-type littermates were fed a HFD 
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with or without β-GPA for 10 weeks. β-GPA treatment again prevented the increase in 
mEH2O2 and IR in both wild-type and AMPKα2 dominant negative mice fed a HFD. These 
findings indicate that AMPKα2 does not mediate the effects of β-GPA on insulin action, 
supporting the hypothesis that the reduction in mitochondrial H2O2 emission is a primary 
mechanism by which exercise and β-GPA attenuate HFD-induced IR. 
In the context of both acute and chronic manipulation of positive (oversupply) and 
negative (expenditure) cellular energy balance, together these findings support the 
concept that the governance of mitochondrial oxidant production is a primary factor 
regulating insulin sensitivity in skeletal muscle. Following the principles of bioenergetics, 
these data demonstrate that a mild increase in energy expenditure can sufficiently 
attenuate the HFD-induced H2O2 emission and IR. On the mitochondrial level, the 
balance of substrate supply and energy expenditure on a daily basis is critical for 
maintaining a proper cellular redox environment, function and whole body metabolic 
status.  
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The Influence of Energy Expenditure on Mitochondrial Functions, Oxidative Stress and 
Insulin Resistance under Metabolic Oversupply Conditions 
 
CHAPTER 1: Review of Literature 
 
Lipid Metabolism and IR in Skeletal Muscle 
A progressive reduction of insulin sensitivity, particularly in skeletal muscle (the 
major insulin-mediated glucose disposal organ1), is an initial and principle feature in the 
etiology of type II diabetes (T2D)2. The development of insulin insensitivity is associated 
with elevated intramyocellular lipid content and circulating free fatty acid concentration. 
It was suggested that the accumulation of fatty acid metabolites such as fatty acyl-CoAs 
and diacylglycerols (DAG) and/or ceramides directly or indirectly alters insulin 
signaling3-5. One of the main hypotheses is that DAG activates protein kinase C-θ 
(PKC-θ) (or other PKC families) which in turn activates a serine kinase cascade such as 
IKK and cJNK-1 and further phosphorates IRS-1 on one or more serine/threonine 
residues and therefore blocks IRS-1 tyrosine phosphorylation by insulin receptor6-12. In 
turn, insulin-stimulated glucose transport signaling pathway is suppressed and 
ultimately leads to insulin resistance (IR). Chronically, elevated intracellular fatty 
acyl-CoAs may affect the expression and/or activity of PPAR family, PGC-1α and/or the 
NRF-1, in turn altering the expression of some key metabolic related signaling 
proteins13-16. 
 
Mitochondrial Dysfunction Recently Implicated in the Pathogenesis of T2D 
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The precise cause of IR and T2D is still unknown and should be multi-factorial. 
However, a strong association between IR, lipid accumulation and mitochondrial 
dysfunctions has been frequently reported. Insulin resistant populations have elevated 
intramyocellular lipid content17,18. Reduced mitochondrial functions have been shown to 
associate with IR or T2D19-22. These include reduced mitochondrial content23, size23, 
enzyme activity24-26, electron transport system (ETS) complexes and oxidative 
phosphorylation (OXPHOS) activity or respiration16,17,27,28, TCA cycle flux rates29, ATP 
production25,26, decreased expression of OXPHOS related genes15,30,31. Furthermore, 
mitochondrial dysfunction was associated with IR at the early development stage of 
T2D31,32. Thus, it is speculated that mitochondrial dysfunction and associated 
mal-regulation of fatty acid metabolism, particularly in skeletal muscle, is a causal factor 
linked to the development of IR6,33,34. 
 
No Clear Cause–Effect Relationship between Mitochondrial Dysfunction and IR 
Mounting evidence suggests that mitochondrial dysfunction is not the only one, at 
least, primary etiological factor in the development of IR or T2D, but rather represents a 
secondary event. Asian Indians displayed higher mtDNA content, OXPHOS genes 
expression and enzyme activity and ATP production rates in muscle, despite being 
more insulin resistant than age-, sex- and BMI-matched North Americans35. Moreover, 
Asian-Indian individuals with T2D and higher muscle lipid levels have similar 
mitochondrial oxidative capacity compared with Asian Indians without T2D35. 
Post-exercise mitochondrial capacity of phospho-creatinine and ADP recovery kinetics 
measured by in vivo 31P MRS found no differences between sedentary normal controls 
and obese patients in either early or advanced stages of T2D36. A longitudinal Zucker 
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diabetic fatty rat study showed that the development of diabetes is associated with 
increased intramyocellular lipid content, whereas skeletal muscle complex II activity, 
citrate synthase activity remain comparable to the lean heterozygote littermates and 
mitochondrial fatty acid oxidation (FAO) activity was increased compared with lean 
littermates37. Other reports from animal and human studies have also shown high-fat 
diet may not affect38-40, or may even promote41-45 skeletal muscle mitochondrial function.  
It has been reported that skeletal muscle-specific knockout mouse model with 
progressive reduction in each ETS complex I~IV activities does not result in either T2D 
or IR but instead display an increased peripheral glucose uptake46. Mice with either 
muscle-speciﬁc PGC-1α KO or with a loss-of-function mutation of PGC-1β also show 
reduction in OXPHOS genes‘ expression and defects in muscle mitochondrial function; 
however, in these animals, muscle insulin sensitivity is slightly improved compared to 
control mice47,48. On the other hand, muscle-speciﬁc PGC-1α transgenic overexpression 
mice exhibit no alteration in glucose tolerance or insulin sensitivity under standard chow 
diet feeding condition despite improved exercise capacity and increased mitochondrial 
gene expression, mtDNA and mitochondrial enzyme activity compared with wild-type 
littermates49. Other animal models of mitochondrial dysfunction including skeletal 
muscle specific PGC-1α KO mice50 do not show IR. Overall, altering mitochondrial 
function using various gene-manipulation models has failed to demonstrate a consistent 
association between mitochondrial dysfunction and insulin action.  
In fact, a decrease in mitochondrial function observed in insulin-resistant humans 
may not limit muscle fatty acids oxidation nor lead to lipid accumulation22. Recent 
studies in which reduced rates of FAO or total mitochondrial oxidation capacity 
observed in muscle from elderly individuals, family offspring of diabetics, or 
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obese/diabetic have been interpreted as indicative of a diminished FAO capacity17,18,23. 
However, the muscle mitochondrial FAO capacity, such as during maximal exercise, is 
far in excess of the rate measured under resting conditions when energy demand, and 
thus the rate of FAO, is low. In other words, it is questionable whether mitochondrial 
deﬁciencies would have a considerable limitation on the rate of FAO under normal 
resting conditions when energy demand is low22. Moreover, although short-term or early 
stage of HFD feeding could promote mitochondrial density and FAO activity due to a 
prompt adaptive response19,44,51, oversupply of fuel can over-ride mitochondrial 
compensation19. In this context, the imbalance of substrate supply and consumption 
capacity (i.e., energy demand) of healthy mitochondria, but not dysfunctional 
mitochondria, may be a primary factor leading to lipid accumulation and IR 19,42,45. Most 
importantly, and perhaps most germane, it is imperative to recognize that the rate 
of mitochondrial respiration (i.e., oxidative metabolism) in cells is governed 
mainly by energy demand (basal + ADP-driven)52,53. In tissues that mainly rely on 
FAO such as cardiac muscle, it has been shown that the key regulator of FAO is energy 
demand, not substrate supply53. In other words, based on principles of mitochondrial 
bioenergetics, the underlying problem thought to be responsible for the development of 
IR (i.e., intramyocellular lipid accumulation) is created whenever the supply of lipids 
exceeds the energy needs of the cell, independent of mitochondrial content. A reduction 
in mitochondrial density, if it does occur, will reduce overall basal non-ADP driven state 
IV respiration (i.e., basal energy demand) since mitochondria account for approximately 
25% of basal metabolic rate54,55, but the underlying problem if lipid accumulates is still 
supply outpacing demand. 
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The Cause–Effect Relationship between Mitochondrial Oxidative Stress and IR 
It was recently reported that global (80%) as well as tissue specific (muscle- and 
liver-speciﬁc) knockout of apoptosis inducing factor (AIF) ablation caused a pattern of 
progressive OXPHOS deﬁciency (decreased OXPHOS gene expression and complex 
activity but no increased reactive oxygen species (ROS) accumulation due to increased 
respiratory chain coupling) that closely mimicked that of human IR but resulted in 
increased glucose tolerance, a reduced fat mass and increased insulin sensitivity after 
HFD56. In addition, there is much evidence indicating that short-term starvation (up to 36 
h) increases FFA utilization and causes IR, mitochondrial dysfunction57, lower ATP/ADP 
ratio and oxidative stress in tissues58,59 while it is attenuated by small amounts of 
carbohydrate loading57. Recently, it was identified that reduced mitochondrial OXPHOS 
is a consequence rather than a cause of lipid-induced IR in the condition of prolonged 
fasting (60 h)22. These reports lead to the speculation that FAO triggered ROS 
production60,61 maybe a key factor linked to IR. 
Elevated ROS production was found in dexamethasone and TNF-α induced 
insulin-resistant cells while IR in cell and animal models was attenuated when ROS 
production was suppressed by diverse treatments62. A recent study in mice also found 
that skeletal muscle mitochondrial dysfunction (i.e., reduced structure and function) 
does not occur until after several months on a high fat diet, well after the appearance of 
IR63. In this study, C2C12 myotubes cultured with high [lipid] or high [glucose] also 
increased ROS production but was prevented by antioxidant treatment. Addition of H2O2 
in cell culture caused decreased mtDNA levels and citrate synthase activity in C2C12 
myotube while co-culture of H2O2 with N-acetylcysteine, a general antioxidant, 
counteracted these H2O2 effects
63. These data suggest that mitochondrial dysfunction 
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does not precede the onset of IR but results from increased mitochondrial ROS 
production63. Furthermore, our previous work has shown in both rodents and humans 
that high dietary fat intake increases skeletal muscle mitochondrial H2O2 emitting 
potential (mEH2O2) and shifts the cellular redox environment to a more oxidized state (i.e., 
reduced GSH/GSSG ratio) in the absence of any change in mitochondrial respiratory 
function64. Moreover, attenuated mEH2O2, either by treating rats with a 
mitochondrial-targeted antioxidant or by genetically engineering the overexpression of 
catalase in muscle mitochondria of mice, completely preserves insulin sensitivity in 
animal model despite a high-fat diet64. In line with this, acute induction of mitochondrial 
O2¯• production by complex III antagonist antimycin A caused a decreased insulin 
action independent of canonical PI3K/Akt pathway in a cell model. HFD induced IR was 
partially prevented in MnSOD transgenic mice model while MnSOD+/- mice were 
glucose intolerant even on a standard chow diet65. 
Additional evidence supporting a potential role for mitochondrial ROS production 
comes from recent studies with metformin. Metformin is one of the most widely 
prescribed insulin-sensitizing drugs for the treatment of IR and T2D although the 
mechanism is still under debate. Several previous reports have suggested that the 
antidiabetic actions of metformin are mediated, at least in part, by directly reducing 
energy charge66 due to the inhibition of ETS complex I67,68. However, the key 
information that was missed is ROS production. A partial inhibition of complex I may 
alter ROS production by at least two mechanisms: 1) by decreasing the efficiency of 
coupling between respiration and ATP synthesis, resulting a lower ΔΨm and an increase 
in electron flux downstream of complex I, or 2) by reducing reverse electron flux back 
into complex I. Indeed, we recently found that metformin inhibits reverse electron 
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ﬂux-mediated mEH2O2 at ETS complex I in skeletal muscle under therapeutic doses 
approximately 2 orders of magnitude lower than that required to inhibit electron ﬂux in 
the forward direction (respiratory O2 ﬂux)
69. Collectively, these findings suggest that 
reducing oxidative stress is crucial for treating T2D and can be accomplished by 
metformin or reduced energy charge. 
The evidence above places the etiology of IR in the context of mitochondrial 
bioenergetics by demonstrating that mitochondrial oxidative stress serves as both a 
gauge of energy balance and a regulator of cellular redox environment, linking 
intracellular metabolic balance to the control of insulin sensitivity. 
 
Mitochondrial Electron Transport System (ETS) 
Mitochondria electron transport system (ETS) (or more frequently termed as 
mitochondria electron transport chain (ETC)) consists of several multi-polypeptide 
protein complexes (I~V) embedded in the inner mitochondrial membrane (Fig. 1-1) that 
receive electrons from soluble matrix dehydrogenases. These electrons from reducing 
equivalent, NADH and FADH2, with high redox potential (tendency to give up electrons) 
are then transferred through a series of electron carriers in the respiratory system in the 
order of high to low redox potential progressively. Eventually theese electrons are 
transferred to O2 (low redox potential, high tendency to accept electrons), ultimately 
reducing 1/2O2 to H2O. In three of these complexes (I, III and IV), the energy from the fall 
in redox potential across the oxidation-reduction reactions is sufficient to drive the 
translocation of protons from the matrix to the inter-membrane space of the 
mitochondria. This creates a proton gradient across the inner membrane that is 
composed of both the electrical potential (ΔũH
+) and the chemical concentration 
 - 8 - 
 
difference (ΔpH) . Conventionally, ΔũH
+ is converted to units of electrical potential, i.e., 
mV, and commonly referred to as the mitochondrial membrane potential (ΔΨm). 
Although ΔpH and ΔΨm together comprise the total proton motive force (Δp), ΔΨm is by 
far the dominant component and often used synonymously with Δp. The essence of the 
chemiosmotic theory is that the electrical-chemical potential created by the 
accumulation of ΔΨm is sufficient to drive the synthesis of ATP as protons flow back 
through the ATP synthase (complex V) into the matrix. Proton leak constitutes another 
means of re-entry for protons which is more important during basal respiration. In 
non-phosphorylating or very low phosphorylating mitochondria, the rate of proton leak is 
directly proportional to the respiratory rate. 
 
Figure 1-1. The ETS showing electron flow, proton export, and proton reentry driving 
ATP synthesis. Courtesy of P. Darrell Neufer, Ph.D.. 
 
Mitochondrial Respiration States 
As depicted in figure 1-2, the background rate of mitochondria respiratory oxygen 
flux (JO2) is termed state I respiration when oxygen content is sufficient but no any 
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substrate presented. The basal JO2 is termed state II respiration and is defined as the 
JO2 generated in the presence of respiratory substrates (i.g., glutamate, malate, 
succinate, glycerol-3-phosphate, palmitoyl-L-carnitine) but not ADP. If ADP is then 
added into the system, respiration significantly increases to match the drop in ΔΨm that 
occurs as a consequence of rapid proton re-entry via ATP synthesis (complex V). The 
high JO2 that is achieved upon addition of ADP is termed state III respiration. Once all of 
the ADP is converted to ATP, a new basal JO2 will be achieved and is termed as state 
IV respiration. States II and IV respiration are often used synonymously to refer to basal 
(non-phosphorylating) respiration condition. When the oxygen in the system is 
exhausted (anoxia condition), the respiration is stopped and termed as state V 
respiration. 
 
Figure 1-2. Typical experimental trace of mitochondrial respiration in vitro and defined 
mitochondrial respiration states. See text for detail. 
 - 10 - 
 
 
The Fundamental Bioenergetic Control of ROS Production 
ROS are successive one unpaired electron reduction products of molecular 
oxygen en route to the production of water70-73. Mitochondrial respiration is the major 
source of ROS and ETS was believed to leak about 0.15%74 or even 1~2%73,75 of its 
electrons as superoxide (O2¯•) by the addition of one electron to the outer orbital of 
diatomic oxygen. Although the mechanism is still unclear, the majority of mitochondrial 
O2¯• production occurred in the matrix face of complex I, particularly triggered by 
reverse electron flux, and the minority of mitochondrial O2¯• production occurred in the 
inter-membrane space face of complex III. O2¯•, one of the most destructive ROS, is 
very short-lived and rapidly undergoes dismutation either spontaneously or through 
reactions catalyzed by O2¯• dismutase (SOD) to form H2O2. H2O2 may in turn undergo 
further reduction to water by glutathione peroxidase. Other ROS include hydroxyl radical 
(OH•), peroxynitrite (ONOO¯), hypochlorous acid (HOCl) and singlet oxygen (1O2)
76. In 
order for O2 to become reduced by one electron, the reducing potential of the molecule 
donating the electron non-enzymatically needs to be close to or exceed about -160mV 
(the ΔE for conversion of O2 to O2¯•) in physiological condition in vivo
77. Not only do a 
number of redox couple components within the ETS meet this thermodynamic 
requirement, many steps involve single electron reactions.  
As depicted in figure 1-4 (proved in figure 2-7) that under state IV and low state 
III respiration condition, the rate of mitochondrial ROS production is highly dependent 
on ΔΨm and inversely related to the availability of ADP used to drive ATP synthesis
78-80. 
In low state III condition, decreasing of ADP levels (i.e., ↑ ATP and ↓ energy demand) 
induces an increase in the ΔΨm, which, in turn, decreases the respiratory rate and 
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further leads to stimulation of O2¯• generation due to the relatively higher reduced state 
of the ETS components. In state IV condition, without ADP supply, the ΔΨm is very high 
and an exponential increase in O2¯• generation occurs within a small range of ΔΨm 
values exceeding about -160mV79,81-84. The inverse occurs when the mitochondrial ADP 
levels rise (↑ energy expenditure) which lead to the reduction of the ΔΨm through F1F0 
ATP synthase complex activity85,86. 
From the preceding discussion, it is clear that a chronic increase in metabolic 
substrate oversupply without a corresponding increase in energy demand results in 
elevated ROS production and IR19,63,87. It follows from the principles of bioenergetics 
that, when close to state IV respiration condition, a small increase in energy expenditure 
can reduce ΔΨm and may be sufficient to lower ROS production and prevent IR under 
metabolic substrate oversupply condition. This is the central question of this proposal.  
 
Redox-Sensitive Protein Modification – Potential Mechanism linking ROS to IR 
As detailed above, compelling evidence is accumulating suggesting a cause and 
effect relationship between mitochondrial ROS production and IR under HFD and T2D 
conditions in cell, animal, and human models62-65. However, the detailed molecular 
pathway as to how ROS leads to IR is still not clear. Other than causing oxidative 
damage (e.g., lipids, proteins or DNA), ROS have been implicated in several serine 
kinases that target and disrupt IRS-1 signaling88. ROS activates a number of 
stress-sensitive signaling pathways such as the NFκB/IKB/IKKβ signaling pathway 
which can lead to the phosphorylation and inactivation of IRS-1. Pharmacologically or 
genetically blocking this pathway has been shown to protect against HFD-induced IR89. 
To go one step further, what is the mechanism that makes signaling pathways 
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redox-sensitive and insulin sensitivity potentially redox-regulated? Both mitochondrial 
proteins and insulin signaling proteins appear to be regulated by redox-sensitive protein 
modification which alters protein function and insulin sensitivity. 
The thioether (-S-) of methionine (Met) and the better studied thiol (-SH) of 
cysteines (Cys) are the two common functional groups that undergo reversible 
oxidation-reduction reactions mediated by ROS, reactive nitrogen species (RNS), lipid 
hydroperoxides, aldehydes, quinones, disulfides (e.g. GSSG) and others90. What makes 
Cys residues particularly redox-sensitive and proteins potentially redox-regulated? The 
reactivity of regulatory Cys thiol modification is mainly determined by the Cys‘s 
structural environment and its pKa value91. Most cytoplasmic protein thiols have pKa 
values of greater than 8.0, which render the thiol groups predominantly protonated and 
largely nonreactive at intracellular pH91,92. On the other hand, thiol groups of 
redox-sensitive cysteines have much lower pKa values, ranging from as low as ~3.5 in 
thiol transferase to ~5.1 to 5.6 in protein tyrosine phosphatases91. These thiols are 
therefore present as deprotonated, highly reactive thiolate anions (RS-), under 
physiological cellular pH conditions91,93,94. The low pKa values of redox-sensitive 
cysteines are primarily due to the charge-charge interactions between the thiolate anion 
and neighboring positively charged or aromatic side chains91,95,96. In contrast to their 
protonated counterparts, thiolate anions can easily undergo a diverse spectrum of 
oxidative modifications upon oxidation by ROS or RNS91,97. These thiolate anions 
include disulfide (-SS-), sulfenate (-SO¯)/ sulfenic acid (-SOH), sulfinate (-SO2¯)/ sulfinic 
acid (-SO2H), and sulfonate (-SO3¯)/ sulfonic acid (-SO3H), or nitrosothiols (-SNO) and 
others90,98-100. Fortunately, most common forms in cells are the more reduced 
protonated thiol (-SH) and disulfide (-SS-) species90 while cysteine sulfenic acids and 
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their deprotonated cysteine-sulfenates are remarkably reactive and versatile oxidation 
products, which are frequently formed91.  As detailed by Jones90, the regulation of 
biological functions by redox-sensitive thiols occurs in three general ways: 1) chemically 
alter active site Cys residues (―on-off‖ switch), 2) alter macromolecular interactions, and 
3) regulate protein activity through modification of allosteric Cys. Furthermore, individual 
proteins often contain multiple Cys residues. Different redox-sensitive elements within a 
single protein allow its function to be simultaneously regulated by multiple independent 
redox signals/ mechanisms90. When in response to ROS or RNS, the thiol-based redox 
switches are used as molecular tools in many proteins to regulate their activity including 
either their activation (e.g., OxyR, Hsp33)101,102 or inactivation (e.g., PTEN, 
GapDH)103,104. Reversible oxidative thiol modifications have been found to modulate the 
biological function of proteins involved in many different pathways including receptor 
activation, signal transduction, transcription factor activation, gene expression, 
epigenetic control, cell proliferation, differentiation, senescence and apoptosis, 
metabolism, angiogenesis, protein trafficking, protein synthesis and degradation, 
immune response, cytoskeletal structure and other processes90,91,105-120. 
 
Redox-Sensitive Protein Modification in Insulin Signaling Pathway 
Based on the evidence described below, oxidation of redox-sensitive proteins 
might lead to suppression of insulin signaling via Ras, PKC PI3 kinase, and Akt. 
Conversely, oxidation of a number of redox modified proteins (PTP1B, PTEN, PKA and 
PP2A) could promote improved insulin signaling. 
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Figure 1-3. Summary of potential redox regulation in insulin signaling pathway. See text 
for detail. 
 
IRS 
Both increased degradation and impaired insulin-induced tyrosine 
phosphorylation (activation) of Insulin-Receptor-Substrate protein (IRS) have been 
implicated in oxidant-mediated decrease in insulin action121. In 3T3-L1 adipocytes, H2O2 
incubation induced increased IRS-1 degradation and Ser307 phosphorylation 
(inactivation)122. Incubation with lipid peroxidation product 4-HNE at nontoxic 
concentrations exhibited enhanced IRS-1 and IRS-2 degradation and increased serine 
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phosphorylation of IRS-1 which is alleviated by HNE detoxify enzyme, fatty aldehyde 
dehydrogenase (FALDH)123. In vascular smooth muscle cells, angiotensin II decreased 
IRS-1 protein levels via ROS-mediated IRS-1 Ser307 phosphorylation and subsequent 
proteasome-dependent degradation124.  
Ras 
Even though Ras activates P13K (phosphatidylinositol 3-kinase), which should 
increase insulin action, peroxynitrite mediated glutathionylation on Cys118 and 
consequent activation of Ras resulted in endothelial IR while insulin signaling was 
restored with Glutaredoxin (Grx) overexpression125. 
PKC 
Many PKC isoforms appear to be sensitive to redox inhibition by 
S-glutathionylation or unknown protein modification114,126-128. Among them, atypical PKC 
λ/ζ (aPKC λ/ζ) are the isoforms that link to insulin-stimulated GLUT4 translocation and 
glucose uptake. Purified human recombinant aPKC- ζ is subject to oxidative inactivation 
by S-glutathiolation induced by the concentration-dependent thiol-specific oxidant 
diamide, which induces disulfide bridge formation129. 
PI3K 
High glucose- or peroxynitrite-treated cells showed significant increases in 
tyrosine nitration on the p85 subunit of PI3 kinase and cause its dissociation from the 
catalytic p110 subunit which further blocked PI 3-kinase and Akt-1 kinase activity130. 
Inhibiting peroxynitrite formation or blocking tyrosine nitration of p85 restored the activity 
of PI3 kinase and Akt-1 kinase130. 
Akt (PKB) 
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H2O2 exposure resulted in impaired Akt activation in both 3T3-L1 adipocytes and 
L6 muscle cells131,132, while lipoic acid, by its capacity to maintain intracellular redox 
state, protects against oxidative stress induced impairment in Akt activity133. A link 
between Akt activity and glutathione reductase 1 status was indirectly suggested134, 
although the Akt glutathionylation has not been directly demonstrated. Furthermore, Akt 
is reversibly inactivated by S-nitrosylation135 specifically in Cys224136 or Cys296137. 
Treating with exogenous NO resulted in S-nitrosation of insulin receptor β subunit (IR-β), 
Akt and IRS-1 which led to either decreased enzyme activity or expression. These 
effects were reversed by reduced iNOS expression138 or acute exercise139 yielded an 
improvement in insulin action.  
GLUT4 
Studies suggest that oxidants appear to reduce GLUT4 gene expression by 
either oxidation of transcription factor NF1 or suppression of transcription factor C/EBPα 
expression6,121,140-142. 
PTP1B 
PTP1B (Protein tyrosine phosphatase 1B) negatively regulates both insulin 
signaling pathway and leptin sensitivity91,143-147. The catalytic site Cys215 is reduced in 
active PTP1B148-151. Upon mild oxidative stress (100μM H2O2), a reversible cyclic 
sulfenyl-amide is formed in the Cys215 and leads to PTP1B inhibition by changing the 
conformation of the active site, while the conformational and phosphatase activity 
change can be restored by reducing agents such as GSH or DTT152,153. Similar 
oxidative inhibition of PTP1B has also shown in other studies154-158. 
PTEN 
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The active site Cys residues of PTEN (tumor suppressor phosphatase with 
sequence homology to tensin), which regulates the activity of the PI3 kinase 
signaling91,159, is reversibly oxidized and inactivated by either ROS or RNS. Oxidative 
inactivation of PTEN leads to increased phosphatidylinositol (3,4,5)-trisphosphate (PIP3) 
level and increased Akt–phosphorylation159, which will potentially increase insulin action. 
Further study shown ROS inactivate PTEN by thiol-glutathionylation 
(S-Glutathionylation) and lead to Akt pathway activation160. Inhibition of PTEN by 
peroxynitrite activated the PI3K/Akt pathway161. 
PKA 
PKA (cAMP-dependent protein kinase) acts counter to insulin effect by inhibiting 
lipogenesis and promoting net gluconeogenesis and other effects. PKA is inhibited by 
oxidative glutathionylation162-164 and can be reactivated by thioredoxin165.  
PP2A 
B56 regulatory subunit of the PP2A inactivates insulin signaling through the 
dephosphorylation of Akt166 and AMPK167-170. PP2A is inhibited by H2O2 in a process 
that involves reversible glutathionylation171.  
AMPK 
Although not necessarily due to direct redox-sensitive protein modification, recent 
evidence has suggested that ROS may activate skeletal muscle AMPK activity172,173. 
However, this effect may not directly relate to glucose uptake and other signaling 
proteins may be involved174. In rat skeletal muscle incubated with H2O2, the AMPKα1 
activity was dose-dependently increased, and it was prevented by treatment with the 
antioxidant, Nacetyl-L-cysteine173. Further, contraction-induced increases in mouse 
skeletal muscle AMPK activity were inhibited (~50%) by N-acetyl-L-cysteine 
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treatment172. However, although skeletal muscle incubated with H2O2 increased AMPK 
α1, α2174 and Akt activities174,175, the glucose uptake did not differ between wild type 
and either whole body AMPK α1 knock out or muscle specific AMPK α2 kinase-dead 
mice174. These results suggest that H2O2 stimulated skeletal muscle glucose uptake 
does not require AMPK catalytic activity, activation of other signal proteins may be 
involved. 
Others 
In addition to the above redox sensitive proteins, other key enzymes or 
transcription factors involved in metabolism or insulin action such as Sirtuin 1176, Silent 
information regulator 2 (Sir2)177, NF-kappaB and AP-1178 were also reported to be 
redox-sensitive although no direct evidence has shown specific redox-sensitive active 
site cysteine residues yet. Other metabolic enzymes inculding, muscle creatine 
kinase-M (CK-M)179, glyeraldehyde-3-phosphate dehydrogenase (GapDH)180 and 
carbonic anhydrase 3181 also contain redox-sensitive Cys in their active sites. 
 
Conclusion of Literature Review 
Mitochondrial FAO/OXPHOS capacity and oxidative stress have been implicated 
in the development of IR and T2D. Based on the literature, the reduced mitochondrial 
FAO/OXPHOS capacity may be secondary to the development of IR. Conversely, 
mounting evidence favors a causative role of mitochondrial oxidative stress in the 
etiology of diet induced IR. Metabolic oversupply causes mitochondrial oxidative stress 
and leads to IR; however, how the other side of the metabolic balance equation, energy 
expenditure, may compensate and/or protect against energy oversupply is less 
appreciated. Furthermore, the molecular mechanism of how oxidative stress causes IR 
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is still largely unknown. Redox-sensitive protein modifications may be a crucial 
mechanism for determining how oxidative stress regulates the insulin signaling 
cascade. 
  
Central Hypothesis  
Whole body metabolic imbalance is the underlying cause of metabolic diseases. 
At the cellular level, metabolic balance is a function of how well substrate supply 
matches metabolic demand, and vice versa. Recent research has provided evidence 
that the oversupply of fuel to cells induced by high dietary fat intake elevates 
mitochondrial oxidative stress which, in turn, causally leads to the loss of insulin 
sensitivity62-65. Mitochondrial O2¯• production is directly related to the ΔΨm which, at any 
given time, reflects the balance between 1) the local intracellular rate of ATP utilization 
(metabolic demand) and 2) the rate at which reducing equivalents (NADH and FADH2) 
are presented to the mitochondria; (e.g., ∆Ψm is high, O2¯• or H2O2 emission is favored 
when ATP demand is low and intracellular metabolic supply is high). As such, mEH2O2 
has been proposed to serve as both a gauge of energy balance (i.e., reducing potential 
of the electron transport system) and regulator of redox state within cells, ultimately 
linking cellular metabolic balance to the control of insulin sensitivity64. Our previous 
work64 however tested the impact of nutritional oversupply only under very low demand 
(state IV) respiratory conditions. The interplay between metabolic supply and mEH2O2 
under conditions of ATP turnover (state III) more typical of the conditions present in vivo, 
and the extent to which metabolic expenditure can compensate for over nutrition in 
terms of mEH2O2, cellular redox state and insulin sensitivity is unknown. The objective of 
this study was to examine both chronic and acute influence of energy expenditure as 
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well as the interplay of factors governing mitochondrial function under metabolic 
oversupply conditions on the control of mEH2O2 and IR. It was hypothesized that both 
chronic and acute increases in energy expenditure normalize energy 
oversupply-induced elevated mEH2O2 and IR.  
Specific Aim 1 
To determine if a mild increase in energy expenditure (low intensity 
exercise) is sufficient to attenuate the increase in mitochondrial membrane 
potential, oxidant emitting potential, and the reduction in calcium retention 
capacity in skeletal muscle of rats induced by a single lipid loading. 
Previous findings from our lab provide evidence that state IV mEH2O2 in muscle is 
acutely increased by a single glucose or lipid meal. To further examine the potential 
acute impact of lipid oversupply and low intensity exercise on the interplay between 
energetic expenditure and cellular metabolic supply on the control of ΔΨm, mEH2O2, and 
mitochondrial calcium retention capacity (mCa
2+
RC) particularly under state III condition, 
the following were addressed: 
a) How does substrate supply relative to metabolic demand (i.e., state III 
respiration rate) impact mEH2O2 in permeabilized red gastrocnemius of rats?  
b) How is the governance of mitochondrial OXPHOS capacity and state III ΔΨm, 
mEH2O2, mCa
2+
RC affected by single lipid loading? 
c) Does a single bout of low intensity exercise sufficient to normalize the 
governance of mitochondrial OXPHOS capacity and state III ΔΨm, mEH2O2, 
mCa
2+
RC affected by single lipid loading?  
Specific Aim 2 
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To determine if a chronically modest increase in energy expenditure is 
sufficient to prevent the increase in mitochondrial oxidant emitting potential and 
decrease in insulin sensitivity induced by a high fat diet.  
Increasing physical activity (energy expenditure) represents one of the most 
effective means for reversing IR in skeletal muscle of overweight/obese patients at high 
risk for developing T2D. Beta-Guanidinopropionic acid (β-GPA), an 
antidiabetic/antihyperglycemic agent182-184, is a non-metabolized creatine analog that 
reduces cellular creatine phosphate and ATP content and compensatorily increases 
energy expenditure and mitochondrial biogenesis in rodent skeletal muscle185. It is 
hypothesized that only a small increase in cellular ATP turnover is sufficient to relieve 
the ―reducing pressure‖ (i.e., potential of the respiratory system to leak electrons) and 
thus normalize mEH2O2 and IR in a HFD setting. To test this hypothesis, the following 
were addressed:  
a) Is low intensity daily treadmill exercise sufficient to normalize mEH2O2 and 
preserve insulin sensitivity in rats consuming a HFD?  
b) Is daily treatment with β-GPA sufficient to normalize mEH2O2 and preserve 
insulin sensitivity in rats consuming a HFD? 
Both exercise186-188 and β-GPA185,189-191 have also been shown to activate AMPK, 
and AMPK-mediated signaling is known to stimulate glucose uptake independent of 
insulin192. This suggests that any metabolic effects induced by β-GPA, if occurring, may 
be mediated by AMPK and/or mEH2O2. To distinguish between these two possibilities, the 
following was addressed:   
c) Does β-GPA treatment normalize mEH2O2 and IR in AMPKα2 dominant 
negative mice consuming a HFD?   
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Figure 1-4. Central hypothesis. Mitochondria respiration status in the regulation of ROS 
production rate and redox-sensitive protein modification. HFD causes increases in 
membrane potential and ROS production, which leads to redox-sensitive protein 
modifications within mitochondria and insulin signaling proteins and ultimately leads to 
IR. Increased energy expenditure, however, decreases the membrane potential and 
ROS production, further preserving insulin sensitivity. 
 
Significance 
The interplay between substrate supply and metabolic demand is at the heart of 
cellular metabolic balance and the consequences of metabolic imbalance. These 
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studies provide mechanistic insights on the impact of cellular substrate supply relative to 
energy demand on the control of mEH2O2 and insulin sensitivity. 
 
  
 
 
CHAPTER 2: Low Intensity Exercise is Sufficient to Attenuate Acute Lipid 
Loading-Induced Elevations in Mitochondrial Membrane Potential, H2O2 Emitting 
Potential, and Reduction in Mitochondrial Calcium Retention Capacity in Rat Skeletal 
Muscle 
 
Abstract 
Postprandial lipidemia causes acute oxidative stress. Whether it also acutely 
affects other related mitochondrial parameters is unknown. Based on the principles of 
bioenergetics, mildly increasing mitochondrial respiration (energy expenditure) from 
very low state III respiration condition reduces mitochondrial membrane potential (ΔΨm) 
and exponentially reduces O2¯• generation, and vice versa when substrate supply is 
high. The objective of this study was to determine if a mild increase in energy 
expenditure, by low intensity exercise, is sufficient to attenuate the increases in ΔΨm, 
mitochondrial H2O2 emitting potential (mEH2O2), the potential reduction in mitochondrial 
calcium retention capacity (mCa
2+
RC, an index of the resistance of the permeability 
transition) and oxidative phosphorylation capacity (OXPHOS) in the skeletal muscle of 
rats after a single lipid loading. Sprague-Dawley rats received a lipid oral gavage (20% 
intralipid at 45 Kcal/kg lean body mass, ~12% of the daily total caloric intake) followed 
by either 2h of rest or 1h of exercise (treadmill, 15m/min, 0 grade) after 1h of rest. Red 
gastrocnemius permeabilized myofibers were prepared for measures of mitochondrial 
function. The results show that, without a change in OXPHOS, a single lipid load quickly 
elevates ΔΨm, mEH2O2 and reduces mCa
2+
RC in state IV and/or ―clamped‖ physiological 
state III respiration condition. These effects can be sufficiently attenuated by a single 
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bout of postprandial low intensity exercise. These findings provide evidence that 
several aspects of mitochondrial function, including oxidant production, are very 
sensitive to and dynamically regulated by metabolic status. It further suggests ΔΨm and 
oxidative stress are the preceding factors acutely caused by lipid loading, and may be 
responsible for the loss in mitochondrial density observed in long-term substrate 
oversupply conditions, ultimately leading to mitochondrial dysfunction (reduced 
OXPHOS) and metabolic diseases (e.g. diabetes). The balance of substrate supply and 
energy demand on a daily basis is critical for maintaining a proper cellular redox 
environment and therefore cellular function. 
 
Introduction 
Postprandial lipidemia (hypertriglyceridemia particularly)193-195 and 
hyperglycemia196,197 have been proposed to have acute deleterious effects on metabolic 
regulation and cardiovascular function. In addition to hypertriglyceridemia, circulating 
markers of oxidative stress are elevated following a single high-fat meal193,198-200. Other 
studies also show oxidative stress levels positively correlate with postprandial 
circulating triacylglycerol (TAG) levels193,201. Furthermore, previous findings from our 
group provide direct evidence showing that skeletal muscle mitochondrial H2O2 emitting 
potential (mEH2O2), under state IV respiration, is acutely increased by a single lipid meal, 
and the intracellular redox environment (GSH/GSSG) is shifted to a more oxidized state 
by an acute glucose injection or long-term high-fat feeding64. However, whether a single 
lipid load acutely increases skeletal muscle mitochondria membrane potential (ΔΨm) 
and mEH2O2 particularly under state III respiration, which is a more physiological 
condition, is still unknown. Moreover, it is still under debate whether mitochondrial 
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dysfunction (i.e., oxidative phosphorylation (OXPHOS) capacity), content reduction or 
oxidative stress elevation is the preceding/primary cause of diet-induced insulin 
resistance and type II diabetes. While it has been long observed that a single high-fat 
meal193,198-200,202 acutely induces postprandial oxidative stress, there is limited evidence 
on the effect of postprandial OXPHOS capacity. By examining the effect of an acute 
lipid load on OXPHOS capacity, oxidative stress, and other metabolic parameters, the 
initiating factor leading to diet-induced insulin resistance (mitochondrial dysfunction or 
oxidative stress) may be revealed.  
It may seem unlikely that a single high calorie meal will have detectable 
deleterious effects on metabolic control and that a single bout of mild exercise will 
benefit the overall metabolic condition. However, both may have acute effects at the 
cellular and/or molecular level. It is our hypothesis that chronic diseases associated with 
chronic metabolic imbalance are rooted in the cellular conditions that exist during and 
between meals. Based on the rationale that oxidative stress levels positively correlate 
with postprandial circulating TAG levels193,201 and a single bout (>30 minutes) of aerobic 
exercise can promote fatty acid utilization and activate antioxidant defense pathways 
hours after exercise, many investigators have focused on the effects of prior exercise on 
postprandial lipidemia and oxidative stress. A growing body of evidence indicates that a 
single session of low-moderate intensity aerobic exercise of sufficient energy 
expenditure performed hours before a fat meal reduces postprandial lipidemia193,203-207. 
The energy expenditure level of prior exercise appears to be the major factor influencing 
postprandial lipidemia208. Although a single session of low-moderate intensity exercise 
(walking exercise performed at 50% V
‧
O2max for 90 minutes) decreases postprandial 
hypertriglyceridemia irrespective of the timing of the exercise relative to a high-fat meal 
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(i.e., premeal versus postmeal)205, a single session of prior aerobic exercise seems to 
have limited effect on attenuating postprandial oxidative stress measured by circulating 
oxidative stress biomarkers (trolox equivalent antioxidant capacity, xanthine oxidase 
activity, hydrogen peroxide, and malondialdehyde (MDA))209,210. Contrarily, a single 
session of moderate exercise (1 h of 60% max HR exercise) performed 2 hours  
following a high fat meal (69% kcal% fat) can ameliorate the elevation of postprandial 
oxidative stress markers. Circulating serum lipid hydroperoxides (LOOH) O2¯• 
dismutase (SOD) were decreased immediately after exercise, with LOOH levels 
remaining depressed up to 1 hour post exercise session193. Collectively, it appears that 
significant activation of antioxidant defense pathways may not be required under a 
balanced energetic state (i.e., balanced cellular redox status in the pre-meal exercised 
condition). On the other hand, in the metabolically challenged state (i.e., substrate 
oversupply, post-meal exercise condition), aerobic exercise of sufficient energy 
expenditure theoretically can prevent ROS production due to the increase in 
mitochondrial respiration (i.e., ↑ energy expenditure causing state IV → state III 
respiration shift which markedly lowers the ―reducing pressure‖) and/or the rapid 
activation of antioxidant defense pathways. However, evidence that a mild increase in 
energy expenditure (mild exercise) can attenuate acute lipid loading induced high 
oxidative stress (postprandial lipidemia status) is still indirect and limited193. 
Based on the principles of bioenergetics, the rate of mitochondrial ROS 
production, in close to state IV respiration condition, is highly dependent on ΔΨm and 
inversely related to the availability of ADP used to drive the ATP synthesis78-80. In low 
state III condition, decreasing ADP levels (i.e., ↑ ATP and ↓ energy demand) induces an 
increase in the ΔΨm, which, in turn, decreases the respiratory rate and increases 
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superoxide (O2¯•) generation due to the relatively more reduced state of the ETS 
components. In state IV or very low state III condition, without sufficient ADP supply or 
energy expenditure, the ΔΨm is very high and an exponential increase in O2¯• 
generation occurs within a small range of ΔΨm values exceeding about -160mV 
(method dependent)79,81-84. The inverse occurs when the mitochondrial ADP levels rise 
(↑ energy expenditure) which lead to the reduction of the ΔΨm through F1F0 ATP 
synthase complex activity85,86. It follows the principles of bioenergetics that a small 
increase in mitochondrial energy expenditure from idling should reduce ΔΨm and 
thereby exponentially decrease ROS production under metabolic substrate overload. 
Based on this premise, we hypothesized that mild energy expenditure (low intensity 
exercise) can reduce ΔΨm and mEH2O2 under acute metabolic substrate overload (single 
lipid loading).  
To address this hypothesis, we determined the rate of mEH2O2 as well as ΔΨm and 
mitochondrial calcium retention capacity (mCa
2+
RC) under both state IV and ―clamped‖ 
physiological state III respiration conditions in saponin-permeabilized rat skeletal muscle 
fibers (PmFBs, in situ) harvested after acute lipid ingestion with or without a single 
session of mild exercise. The mCa
2+
RC is an index of the resistance of the permeability 
transition pore (mPTP) opening following matrix Ca2+ accumulation211. The purpose of 
this study was to determine if mild exercise is sufficient to attenuate the potential 
increase in ΔΨm and mEH2O2, and the potential reduction in mCa
2+
RC in skeletal muscle of 
rats after receiving a single lipid load. The results show that, without a change in 
OXPHOS, a single lipid load quickly elevates ΔΨm, mEH2O2 and reduces mCa
2+
RC. These 
effects can be prevented or attenuated by a single bout of low intensity exercise. 
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Methods 
Animals 
Animal studies were approved by the East Carolina University Institutional 
Animal Care and Use Committee. Young male Sprague-Dawley rats (n=8-10/group; 
300~325g; Charles River Laboratories, Inc.) were randomly assigned to each group. 
Rats were maintained on a standard 12h/12h light/dark cycle (7:00 am light) and fed 
with standard chow diet ad libitum. 
Design 
All rats were acclimated to the treatment condition for 3 days. Rats from all 
groups received one single water gavage orally and exercised on a treadmill (20 min of 
15m/min) 2-3 days before receiving the treatment. The day before treatment all rats 
received one single water gavage orally and were not exercised. The day of treatment, 
rats received the following treatment at the times indicated in figure 2-1: 1) Control 
group: fast + water oral gavage; 2) Lipid group: fast  + lipid oral gavage; 3) Ex group: 
fast + water oral gavage + exercise; 4) Lipid+Ex group: fast + lipid oral gavage + 
exercise. The exercise protocol was 60 minutes of moderate walking on the treadmill 
(15m/min and 0 grade). The lipid gavage consisted of a 20% intralipid emulsion (8.37 
MJ/L, Sigma I141) which is an aqueous emulsion of 20% soybean oil (containing 50% 
linoleic acid, 26% oleic acid, 10% palmitic acid, 8% linolenic acid and 3.5% stearic acid), 
2.25% glycerin, and 1.25% egg yolk phospholipids in water. The oral gavage volume 
was 25ml/kg lean body mass for either water or intralipid gavage which yields 45 
Kcal/kg lean body mass. The Charles River Laboratories volume guideline for gastric 
gavage in rats is 20ml/kg whole body mass. Body composition analysis (Echo Magnetic 
Resonance Imaging (EchoMRI-900™), Echo Medical System, Houston, TX) of rats  
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revealed a lean body mass of 79.25±1.087% (M±SD, n=24). After considering the 
energy content and lean to whole body mass ratio, the maximal lipid the animals 
received by a single oral gavage was 45 Kcal/kg lean body mass. This was equivalent 
to only 11.9% of average total daily energy intake in rats fed a regular pellet form of 
60%HFD (Research Diets D12492) as determined by an indirect calorimetry module 
(CaloSys V2.1, TSE Systems) for 48h after a 3-4 day of acclimation period (data not 
shown). 
 
 
Figure 2-1. Experiment design. 
 
Tissue Sampling and Permeabilized Myofibers (PmFBs) Preparation 
Tissue sampling. Immediately after the treatment, the rats were anaesthetized 
(~5 minutes) by IP injection of ketamine & xylazine mixture. Gastrocnemius muscle was 
dissected out within 10 minutes after the treatment was completed. The same portion of 
fresh red gastrocnemius from each rat was immediately trimmed, 
saponin-permeabilized, and maintained (4oC) in buffer to determine ΔΨm, mEH2O2, JO2 
and mCa
2+
RC.  
Myofiber separation. Brieﬂy, after dissection, connective tissue was removed and 
fresh ﬁber bundles were separated to maximize the exposure surface using ﬁne forceps 
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under a binocular dissecting microscope in ice-cold buffer X containing (in mM) 60 
K-Mes, 35 KCl, 7.23 K2EGTA, 2.77 CaK2EGTA, 20 imidazole, 20 taurine, 5.7 ATP, 15 
phosphocreatine 6.56 MgCl2·6H2O (pH adjusted to 7.10) plus 0.5 glutamate (G) and 0.2 
malate (M). 
Myofiber permeabilization and washing. After separation, cytosolic membrane of 
myoﬁber bundles were permeabilized in buffer X plus 0.5mM G, 0.2mM M and 40 μg/ml 
saponin gently shaken on a rocker at 4oC for 30 min. To washout the 
extra-mitochondrial components, the PmFBs were further washed (3 x 5~8 min) in 
buffer Z containing (in mM) 105 K-Mes, 30 KCl, 10 K2HPO4, 5 MgCl2·6H2O and 
0.5mg/ml bovine serumalbumin (pH adjusted to 7.40) plus freshly added 1 EGTA, and 
gently shaken on a rocker at 4°C. 25µM blebbstatin (myosin II inhibitors, inhibition of 
contraction212-215) was added into the buffer of 3rd washing. 
Measuring Mitochondrial Respiration Rate (JO2) or JO2 Simultaneously with 
Mitochondrial Membrane Potential (ΔΨm) in PmFBs 
Washed PmFBs (~0.5mg after freeze-dried) ΔΨm and/or JO2 was measured by 
high-resolution respirometry (Oroboros Oxygraph-2 K (O2K), Innsbruck, Austria) at 
25°C in assay buffer containing buffer Z plus 1mM EGTA, 25μM blebbistatin and 20mM 
creatine under the following protocols. JO2 protocol: 2mM M + 25µM 
palmitoyl-L-carnitine (PC) + 2mM ADP + 5mM G + 10mM succinate (S) + 10µM 
cytochrome C (Cyto C) (as a quality control of the PmFB preparation) + 10µg/ml 
Oligomycin (Oligo, inhibitor of mitochondrial ATP synthase) + 2µM FCCP 
(carbonylcyanide-p-triﬂuoromethoxy-phenylhydrazone, a potent protonophoric 
uncoupler of OXPHOS). In another protocol, JO2 & ΔΨm were simultaneously measured 
from the same PmFBs. The newly developed Oroboros tetraphenylphosphonium (TPP+) 
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-selective electrode is an ion selective electrode (ISE) that integrates into the O2K 
chamber for simultaneous recording of oxygen and TPP+. TPP+ accumulates in the 
mitochondrial matrix as a function of the ΔΨm. 2U/ml hexokinase (HK)/ 5mM 
2-deoxyglucose (2-DOG)/ 10mM G/ 15mM pyruvate (Pyr)/ 2mM M/ 10mM 
Glycerol-3-Phosphate (G3P)/ 10mM S were added into the chamber in the beginning. 
After the pTPP+ signal reaches a steady status, the TPP+-selective electrode was 
calibrated by a 5 point titration range from 1.1 to 1.5µM TPP+. The sensitivity was 
calculated from the actual TPP+ working range. PmFB was added into the chamber to 
obtain the maximal state IV ΔΨm and JO2. An ADP titration (25, 50, 100, 250, 500, 1000, 
2000μM) was followed to obtain the kinetics of state III ΔΨm and JO2. Finally, 2µM 
FCCP was added to collapse ΔΨm driven TPP
+ uptake. The criteria of steady state 
pTPP+ signal (gain of 10) in each condition is defined as below: raw pTPP+ slope = 0 to 
0.003 mpTPP+/s during TPP+ titration; 0 to -0.002 mpTPP+/s in 0-250µM ADP; 0 to 
-0.003 mpTPP+/sec in 500µM ADP; 0 to -0.006 mpTPP+/sec in 1000 and 2000µM ADP. 
The mathematics of ΔΨm is based on classical Nernst equation with binding correction 
factors and assumed mitochondrial protein content to freeze dried muscle fiber weight 
ratio. Oroboros TPP+-ΔΨm calculation template (http://www.oroboros.at for detail) was 
used with minor modifications in order to apply the internal chemical background 
correction factor. This correction factor is defined as the instantaneous difference of 
stable signal between immediately before and 4-8 seconds following the chemical 
addition, which causes an artificial signal spike. It is based on 2 observations: 1) Due to 
the structure nature of PmFB, it appears that the re-distribution of TPP+ upon substrate 
addition is much slower (than cell or isolated mitochondria) although the change in ΔΨm 
may occur sooner, 2) ADP instantly causes a dose-dependent steady chemical 
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background effect (small reduction) on pTPP+ signal in a system without biological 
sample. Equation as below:   
 
 nadd: total amount of probe ions added to the system. 
 Cext,free: free concentration of probe ion outside mitochondria. 
 Vext: external volume: total solution volume outside mitochondria. 
 Vmt(spec): mass specific mitochondrial matrix volume (per mass of mitochondrial 
protein) = 1µl/mg216-218. 
 Ki': apparent partition coefficient describing internal binding = 7.9µl/mg
216.  
 Ko': apparent partition coefficient describing external binding = 14.3µl/mg
216.  
 Pmt: total mitochondrial protein content (as a marker for mitochondrial membrane 
content). Assumed to be 15% of freeze dried muscle fiber weight.  
 Pc: total cellular protein content (as a marker for cellular membrane and other 
material content) = freeze dried muscle fiber weight. 
Measuring Mitochondrial H2O2 Emitting Potential in PmFBs  
The mEH2O2 of PmFBs (~0.3mg after freeze-dried) was measured by continuously 
monitoring fluorescence probe Amplex Ultra-Red (Invitrogen, A36006; 
excitation/emission: 568/581nm) using Fluorolog-3 (Horiba Jobin Yvon, Edison, NJ) 
spectroﬂuorometers with temperature control at 25°C and magnetic stirring. mEH2O2 
protocol 1 is a parallel protocol of JO2 & ΔΨm protocol. The assay buffer condition is the 
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same with additional 2U/ml HK/ 5mM 2-DOG/ 6 U/ml HRP/ 25 U/ml CuZn-SOD/ 50µM 
Amplex Ultra-Red. After establishing a background fluorescence rate in the presence of 
a PmFB, the reaction is initiated by the addition of sequential substrates, 
G/Pyr/M/G3P/S+ADP titration (same concentration as in JO2 & ΔΨm protocol). For 
mEH2O2 protocol 2 and 3 the assay buffer condition is the same as JO2 & ΔΨm protocols 
with additional 6U/ml HRP/ 25U/ml CuZn-SOD/ 50µM Amplex Ultra-Red. After 
establishing a background fluorescence rate in the presence of a PmFB, the reaction is 
initiated by either 10mM G3P + 25µM PC in protocol 2 or 10mM S + 10mM G3P in 
protocol 3. mEH2O2 production rate is calculated from the slope of ΔF/min, after 
subtracting background, using a standard curve established for each reaction condition. 
Measuring Mitochondrial Calcium Retention Capacity (mCa
2+
RC) in PmFBs 
The PmFBs (~0.2mg after freeze-dried) mCa
2+
RC were measured by continuously 
monitoring fluorescence probe calcium green 5N salt (Ca5N, Invitrogen, C3737; 
excitation/emission: 506/532 nm) using Spex Fluoromax 3 (Horiba Jobin Yvon, Edison, 
NJ) spectroﬂuorometers with temperature control at 25°C and magnetic stirring. The 
assay buffer condition is the same as JO2 & ΔΨm protocol with only 40µM EGTA and 
additional 2U/ml HK/ 5mM 2-DOG/ 1µM Ca5N/ 1.5 µM thapsigargin (sarco/endoplasmic 
reticulum Ca2+-ATPase inhibitor). The assays were started with the G/Pyr/M/G3P/S 
(same concentration as in JO2 & ΔΨm protocol) plus 0, 25 or 500µM ADP in each 
individual experiment. After a steady background fluorescence intensity is obtained 
(~5min), the first pulse CaCl2 of 75µM is added followed by 50µM pulses of CaCl2 at the 
time interval of 15-30min/pulse based on the Ca2+ uptake rate. The fluorophore 
fluoresces in the presence of extra-mitochondrial Ca2+, so that a decline in fluorescence 
intensity is indicative of mitochondrial Ca2+ uptake. PTP opening is evident when 
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mitochondria start to no longer take-up or rapidly release Ca2+. In the end, 2.5mM CaCl2 
was added followed by 1~2 additions of 0.67mM CaCl2 to obtain fluorescence of the 
calcium-saturated probe in order to quantify the total Ca2+ uptake.   
At the conclusion of each experiment, PmFB were washed in ddH2O to remove salts 
and then freeze-dried in a lyophilizer (LabConco). JO2, mEH2O2 and mCa
2+
RC were 
normalized to dry tissue weight. 
Statistics 
All statistical analysis was performed using GraphPad Prism 5.02 (GraphPad 
software, San Diego, California). Unless specified otherwise, data are presented as 
mean ± S.E.M. from n=8~10/group. The statistical differences among groups under the 
same substrate or ADP concentration condition in each experiment was analyzed using 
the independent one-way ANOVA with Tukey post-hoc test. Statistical significance 
power was set at p<0.05. Since the ―ceiling effect‖ was observed, independent T-tests 
were used for ΔΨm data with statistical significance power set at p<0.1. 
 
Results 
Neither Single Lipid Loading nor Low Intensity Exercise Affect Mitochondrial Respiration 
Capacity 
To determine if a single lipid loading or exercise has an effect on mitochondrial 
respiration (JO2) capacity in skeletal muscle of rats, we measured JO2 in PmFBs from 
the red gastrocnemius muscle. Neither single lipid loading nor exercise had a significant 
effect on palmitoyl-carnitine-supported maximal JO2 capacity in combination with 
complex I (malate/ glutamate) or complex II substrate (succinate), nor maximal 
uncoupled FCCP-stimulated JO2 (Fig. 2-2).  
 - 36 - 
 
Low Intensity Exercise Attenuates Elevated State IV mEH2O2 Associated with Single Lipid 
Loading 
It is not clear if single lipid loading induced ROS production potential can be 
attenuated by a post-meal low intensity exercise, although indirect data from single 
moderate exercise are available193. In this study, state IV ROS production mediated by 
succinate-induced reverse electron ﬂux and/or lipid based substrates including 
glycerol-3-phosphate and palmitoyl-L-carnitine were measured from PmFBs. As shown 
in figure 2-3, single lipid loading caused a two fold increase in mEH2O2 versus untreated 
rats (P<0.05) in each substrate condition. This effect was nearly or completely 
normalized under all substrate conditions when low intensity exercise was performed 
after lipid ingestion. 
Low Intensity Exercise Attenuates the Single Lipid Loading-Induced Increase mEH2O2 
and Reduction in mCa
2+
RC with Slight Increase in JO2 and Reduction in ΔΨm in State III 
Condition 
To further test whether low intensity exercise attenuates the single lipid 
loading-induced mEH2O2 under more physiological respiratory conditions, a series of 
kinetic experiments were performed in PmFBs across a wide range JO2 levels (clamped 
state III). 
JO2 and ΔΨm in both state IV and III conditions. The control experiment, figure 
2-4 (A), showed no inhibition of 1.5µM TPP+ on PmFB JO2 under the same substrate 
protocols as in figure 2-5 or 2-6 (A). The TPP+ electrode used showed a relatively high 
sensitivity (53.56±3.03mV/Decade, mean±SD, n=36; 59.13mV/Decade in theory) under 
our experimental conditions (Fig. 2-4 (B)). Shown in figure 2-5 are the representative 
traces from the control experiment. We simultaneously measured JO2 and ΔΨm 
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supported by multiple substrates across a wide range of state III respiration levels (ADP 
titration). The quantified data (Fig. 2-6. (A)) show a single lipid loading slightly increases 
ΔΨm with very little effect on JO2 while low intensity exercise performed after lipid 
loading causes a mild increase in JO2 and normalizes the single lipid loading-induced 
increase in ΔΨm across multiple [ADP] conditions. It appears mitochondria are operating 
in a relatively tight ΔΨm range (-145 to -170mV) across different JO2 states.  
mEH2O2 in both state IV and III conditions. As expected, mEH2O2 decreased rapidly 
in the transition from State IV to State III respiration. In addition, consistent with the ∆Ψm 
data (Fig. 2-6. (A)), mEH2O2 was highest after lipid loading but was normalized to at or 
below control rates when low intensity exercise was performed after the lipid loading 
(Fig. 2-6. (B)). A slightly higher JO2 with the similar ΔΨm may explain the observation of 
lower mEH2O2. 
mCa
2+
RC in both state IV and III conditions. The mitochondrial permeability 
transition pore is sensitive to various cellular stresses including calcium219-221 and 
ROS222,223. Figure 2-6 (C) shows low intensity exercise partially attenuated the single 
lipid loading-induced reduction in mCa
2+
RC under state III but not state IV conditions.  
 
Discussion 
Although postprandial systemic oxidative stress has long been observed 
following a lipid rich meal202, the potential acute impact of lipid rich meals on 
mitochondrial function has not been studied.  Furthermore, the benefits of regular 
exercise on metabolism, as well as mitochondria related effects, have been greatly 
acknowledged. Whether post-meal mild exercise may ameliorate the lipid induced 
postprandial oxidative stress and related defects is still not clear. More direct and 
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physiological evidence from mitochondria in working skeletal muscle is required to 
establish this relationship. In this context, our results provide evidence that, in the 
absence of mitochondrial dysfunction (in terms of JO2 kinetics and maximal capacity) 
skeletal muscle mEH2O2, ΔΨm and mCa
2+
RC are acutely sensitive to changes in metabolic 
status. There are several important and novel findings from the present study. First, 
acute lipid overloading induced by oral gavage of ~12% of daily total caloric intake 
(when fed with high fat diet) increased state IV mEH2O2 under multiple substrate 
conditions. This change in mEH2O2 occurred in the absence of any change in respiratory 
function. Second, mild exercise performed after the lipid load completely prevented the 
increase in mEH2O2. Third, consistent with the mEH2O2 data, state IV ΔΨm was highest 
after acute lipid loading and lowest when exercise was performed after lipid loading. 
State IV JO2 was also slightly elevated in the lipid plus exercise group. Fourth, as 
expected, transitioning to state III respiration sharply decreased both ΔΨm and mEH2O2. 
However, the greater ΔΨm and mEH2O2 induced by lipid load and apparent protection 
afforded by exercise present under state IV was also evident under mild to moderate 
state III respiratory conditions. Fifth, also under mild to moderate state III conditions, 
acute lipid load decreased mCa
2+
RC, indicative of altered permeability transition pore 
function. Together, these findings provide strong evidence that mitochondrial 
oxidant production and related effects are very sensitive and dynamically regulated by 
metabolic status. It suggests an increase in ΔΨm for a given substrate condition may be 
a primary factor driving the downstream cellular consequences of lipid loading, and that 
the increase in ΔΨm is attenuated by mild exercise. Although further work is certainly 
required, it is tempting to speculate that the cumulative effects of transient increases in 
oxidant production following lipid meals may be responsible for the loss of mitochondria 
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density observed in long-term substrate oversupply conditions, ultimately leading to the 
mitochondrial dysfunction associated with metabolic diseases (e.g. diabetes). At the 
mitochondrial level, the balance of substrate supply and energy demand on a daily 
basis is likely critical for maintaining proper cellular redox environment and therefore 
cellular function and whole body health. 
Several studies have observed an increase in oxidative stress with obesity, 
diabetes21,63,64,224, and a number of other diseases225-227. The common mEH2O2
62-64,228-230, 
ΔΨm
231 and mCa
2+
RC
232-235 measurements are frequently performed under state IV 
respiration conditions. However, experimental state IV mitochondrial respiration does 
not exist in vivo, as different levels of state III respiration, based on metabolic status, are 
closer to the physiological condition in vivo. Thus, further evidence from state III 
respiration is required to examine the potential link between metabolic disease and 
mitochondrial ROS production, as well as ΔΨm and mCa
2+
RC in a more physiological 
manner. With the newly developed hexokinase dependent ADP regeneration 
system81,85,86,236,237 in PmFBs64,228,229, in situ state III ―clamp‖ technique was successfully 
developed in our laboratory236. A second ADP regeneration system (endogenous 
mitochondrial creatine kinase and additional creatine81,86,238) was also applied in this 
study to maximize efficiency. We used this technique to investigate the relationship 
between substrate supply and metabolic demand on ΔΨm and ROS production across 
different JO2 levels which mimic different metabolic/physical activity states. Contrary to 
the widely held belief that electron leak and O2¯• formation occur only under state IV 
conditions, our findings (Fig. 2-6. (B)) reveal relatively low but appreciable mEH2O2 even 
under moderate-high state III conditions. These findings suggest that ROS production 
does occur in vivo and studies should be conducted under state III more typical of the 
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condition present in vivo. Based on the kinetics‘ relationship (Fig. 2-6), by clinically 
manipulating different mitochondrial respiratory levels, the energy expenditure level 
required to normalize the over nutrition induced oxidative stress can be revealed at the 
mitochondrial level.  
The present data shows that acute lipid loading had no clear effect on 
mitochondrial OXPHOS capacity, while it elevated the ΔΨm, mEH2O2 and reduced 
mCa
2+
RC. These findings suggest that reduced OXPHOS capacity is less likely the 
preceding factor of long-term HFD induced mitochondrial defect and related metabolic 
diseases. Evidence for reduced mitochondrial OXPHOS activity or respiration16,17,27,28 
has been shown to associate with long-term substrate oversupply such as occurs with 
IR or T2D. However, mounting evidence also suggests that mitochondrial dysfunction 
represents a secondary event in the development of IR or T2D35-37,63,64. In fact, 
short-term or early stage HFD feeding could actually promote mitochondrial density and 
fatty acid oxidation activity due to a prompt adaptive response19,42,44,51. Our 
mitochondrial respiration data support this idea in which significantly reduced 
mitochondrial OXPHOS capacity is less likely to occur in the beginning, at least, of lipid 
loading. Instead, our data further indicate that oxidative stress and related parameters 
can be elevated very quickly by lipid overloading and could be the preceding or among 
the primary factors that leads to metabolic diseases.  
The treatment effect on mEH2O2 is clear. However, whether the mEH2O2 change 
was contributed by the treatment effect on mitochondrial oxidant production and/or 
anti-oxidant scavenging/buffering system (i.e., GSH/GSSG, thioredoxin and others) is 
unknown. Previous findings from our group provide evidence showing that skeletal 
muscle intracellular redox environment was acutely shifted to a more oxidized state 
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(reduced GSH/GSSG ratio) by an acute glucose injection64 with a lower caloric loading 
compare with this study. In addition, it was shown that lipid rich meal acutely cause 
more oxidative stress than iso-caloric CHO rich meal202. With these, the GSH/GSSG 
ratio after lipid loading may be reduced and indicates a reduced anti-oxidant 
scavenging/buffering capacity. Further, since the ΔΨm was affected by the treatments, 
this may indicate a change in oxidant production potential as well. Further study is 
required to confirm it. 
Although ROS production and OXPHOS capacity have been well studied, the 
impact of metabolic imbalance on ΔΨm, which is the fundamental control of ROS 
production, is relatively less understood. Despite data from cell or isolated mitochondria 
using fluorescent imaging and/or ﬂow cytometry, the evidence from in situ or even in 
vivo experiments show the metabolic intervention on ΔΨm under state III condition 
without using any mitochondrial complex inhibitor is still very limited. In this study, the 
ΔΨm and the rate of oxygen consumption were simultaneously measured by Oroboros 
oxygraph with newly developed TPP+-selective electrode. Not only does the TPP+ 
method provide better sensitivity and quantification, the ΔΨm data in this study also has 
higher physiological relevance since it was measured from PmFBs in situ, the first such 
data reported under state IV-III respiration kinetic conditions.  
Prior research shows that a 6hr lipid infusion decreases ΔΨm by 33% of 
non-energized resting human intact skeletal muscle fibers by using TMRE stain and 
confocal239. However the better quantified ΔΨm under energized status is unknown. The 
present data show slightly increased energized state III ΔΨm in acute lipid loaded rats 
which was prevented by exercise. Interestingly, ΔΨm during low JO2 states was not 
affected by lipid loading but tended to be lower when followed with exercise. The lipid 
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group had the highest ΔΨm without affecting JO2. The state III ΔΨm was similar between 
control, exercise, and lipid+exercise groups, but JO2 tended to be higher in the exercise 
group. Our data indicate higher ΔΨm and ROS production can be caused in a short time 
by lipid loading if no increased in energy demand. Although it was shown that skeletal 
muscle uncoupling protein 2 (UCP2) and UCP3 mRNA levels was enhanced in lean 
Zucker rats after 24h intralipid continuously infusion240, the protein level is unlikely be 
different within 2h after the lipid loading in our study. Further, it was shown that fatty 
acid promote UCP2 and 3 activity241,242 which should attenuate the mEH2O2, ΔΨm and 
maybe even reduce JO2 in some degree. In our study, however it seems that 
uncoupling protein (UCP) activity is less likely a significant contributing factor since both 
mEH2O2 and ΔΨm are still high while JO2 is unaffected. On the other hand, it seems 
exercise activates respiratory enzymes which make the mitochondria more coupled and 
therefore more able to maintain ΔΨm when subjected to a given substrate stress under 
state III condition. Similar lipid effects were found from other laboratories. A trend for an 
increase in succinate supported state IV ΔΨm or proton leak kinetics (the kinetic 
relationship of H+ ﬂux to ΔΨm through simultaneous recording of oxygen consumption 
and potential) has been reported in isolated skeletal muscle mitochondria of C57BL/6 
mice243 and S-D rats244 on a long term HFD. Isolated liver mitochondria from diabetic 
Goto-Kakizaki (GK) rats show higher ΔΨm under both energized state IV
245,246 and low 
state III245 respiration when compared with control Wistar rats245, although no ΔΨm 
difference was found in isolated brain, kidney, skeletal muscle mitochondria in the same 
animal model246 or isolated cardiac mitochondria from streptozotocin-induced diabetic 
rat model247. However, some neutral or opposite results were also found. Isolated liver 
mitochondria from rats fed a HFD for 7 weeks show no change in succinate supported 
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state IV ΔΨm, proton leak rate/kinetics, and maximal state III ΔΨm, although increased 
oxidative stress and impaired glucose tolerance were observed237. In addition, despite 
increased oxidative or nitrosative stress, high glucose and/or high FFA cultured 
adipocytes248 and isolated liver mitochondria from 16 weeks HFD fed mice249 both show 
decreased ΔΨm in an energized state
248. Collectively, the development of oxidative 
stress is very consistent, but the impact of lipid loading on ΔΨm is less predictable 
depending on the: energy status or substrate condition, duration of the metabolic 
intervention, and method of ΔΨm measurement. Even though inconsistent data has 
been found, ΔΨm appears to operate within a small range in a given substrate condition 
and is less easily affected by a metabolic intervention (i.e., a ceiling effect). In the 
short-term, when substrate supply is high without an increase in energy expenditure, it 
tends to cause high ΔΨm. However, if the high lipid is continued, ΔΨm and ROS may 
cause lipid-enriched mitochondrial membrane composition modifications and structural 
damage, which could impair the ability of mitochondria to develop a sufficient ΔΨm and 
eventually cause reduced ΔΨm, OXPHOS capacity and mitophagy although ROS 
production is still high.  
Reduced mitochondrial density is a prominent characteristic of skeletal muscle 
from obese/diabetic individuals. The implication is that prolonged nutritional overload 
leads to mitochondrial degeneration and loss of mitochondrial content due to mitophagy 
and/or mitoptosis. The mPTP is a large conductance channel in the mitochondrial inner 
membrane comprised of multiple proteins which have not been fully identified. mPTP is 
sensitive to various cellular stresses, including calcium219-221,250 and ROS222,223,250. The 
opening of the mPTP triggers the collapse of ΔΨm, release of pro-apoptotic factors, and 
mitochondrial degeneration. mCa
2+
RC is a negative indicator of the susceptibility of 
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permeability transition pore opening, or apoptosis upon matrix Ca2+ accumulation. An 
increase in ΔΨm and reduced cell viability have been shown in cells either cultured with 
high glucose or fructose233. However, the direct evidence of substrate acute or over 
supply on mCa
2+
RC is limited, not to mention in vivo or in situ conditions. Although partial 
negative effects have been reported251, both single bout endurance exercise218 and 
long-term regular endurance training252 have been shown to improve mCa
2+
RC under 
different stress states. Our data further show that under clamped state III respiratory 
conditions, supported by multiple substrates, low intensity exercise attenuates the single 
lipid loading mediated reduction (~35%) in skeletal muscle mCa
2+
RC in situ. This is the 
condition predominantly stressed by Ca2+. During state IV, however, there is no clear 
treatment effect on mCa
2+
RC. It may be due to the synergized effect of the Ca
2+ stress 
and relatively high state IV ΔΨm and mEH2O2 that exceed a certain threshold regardless 
of the treatment effect. In addition, a striking mCa
2+
RC difference between state IV and 
state III respiration condition was also observed. Under low state III condition (50µM 
ADP), mCa
2+
RC is dramatically increased when compared with state IV. However, there 
was only a minimal difference in mCa
2+
RC between low and high state III respiration 
conditions. It has been previously reported that the sensitivity of the mPTP opening to 
matrix Ca2+ accumulation can be greatly reduced by ATP and ADP due to their ability to 
act as substrates of the adenine nucleotide translocase (ANT)250,253,254. By default, 
reduction in ΔΨm and ROS production under state III respiration also plays a role. This 
exponential relationship between ADP levels (or JO2 levels) and Ca
2+-induced mPTP 
opening sensitivity brings up the physiological concern of experimental conditions 
similar to the ROS production measurements. Similar mCa
2+
RC experiments were often 
performed under state IV condition supported with multiple substrates or even solely 
 - 45 - 
 
with high superoxide-causing succinate. However, a more preferred condition to 
evaluate the mCa
2+
RC should be performed under ―clamped‖ moderate state III condition 
supported with multiple substrates which mimic the more physiological substrate 
condition and the levels of JO2, ΔΨm and mEH2O2. It is well known that both high ΔΨm 
and ROS trigger mitochondrial permeability transition although the mechanism is still 
largely unknown. Recent advances in redox biology identified the structure and 
enzymatic activity of proteins within the mPTP complex that are capable of undergoing 
reversibe redox modification could be responsible for mPTP opening255-257. Collectively, 
these findings suggest that exercise may ameliorate the higher level of mitophagy 
and/or mitoptosis normally associated with long-term substrate oversupply (e.g., obesity 
and diabetes) by preserving the reduced redox status of the mPTP complex due to the 
exercise-induced increase in JO2 and the associated reduction in ΔΨm and ROS 
production. 
It has been shown long-term over nutrition, particularly lipid, is associated with 
oxidative stress and could causally lead to insulin resistance and mitochondrial 
dysfunction63,64. It is less appreciated how a single metabolic challenge could 
dynamically affect the control of mitochondria, (e.g. JO2, ΔΨm, ROS production and 
apoptosis susceptibility). Our data suggest that ΔΨm is in a constant state of flux during 
the day, depending on 1) the local intracellular rate of ATP utilization and 2) the rate at 
which reducing equivalents are presented to the mitochondria relative to energy 
demand (e.g., low ATP demand and high intracellular energy supply raise ΔΨm, high 
ATP demand lowers ΔΨm). Keeping in mind that the ΔΨm at which superoxide begins to 
form significantly is fairly high (i.e., more negative than about -160mV), we envision (Fig. 
2-8) that ΔΨm oscillates above and below this threshold during the course of the day, 
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particularly in skeletal muscle. The more time spent inactive and under a positive 
energy balance, the more time ΔΨm is likely to exceed the threshold, thus favoring 
mitochondrial ROS production and apoptosis susceptibility. Conversely, the more time 
spent active and in metabolic balance, the less ΔΨm will rise above the threshold at 
which electrons leak to oxygen. 
 
Conclusion 
The interplay between substrate supply and metabolic demand is at the heart of 
cellular metabolic balance and the consequences of metabolic imbalance. This study 
provides mechanistic insights on the acute impact of cellular energy supply relative to 
demand on the control of ΔΨm, ROS production, and apoptosis susceptibility. Our data 
emphasize the deleterious effects of acute lipid oversupply at the mitochondrial and 
cellular level can occur rapidly, but can be sufficiently counterbalanced by mild increase 
in energy demand (low intensity exercise). Increased energy expenditure is fundamental 
to the preservation of mitochondrial function/integrity and/or for preventing oxidative 
stress on a daily basis. 
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Figure 2-2. A single lipid loading or low intensity exercise has no effect on muscle 
mitochondrial respiration capacity. PmFBs mitochondrial respiration capacity was 
supported by: 2mM malate/ 25µM palmitoyl-L-carnitine (M/PC) + 2mM ADP + 5mM 
glutamate (G) + 10mM succinate (S) + 10µM cytochrome C (Cyto C) + 10µg/ml 
oligomycin (Oligo) + 4µM FCCP. 
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Figure 2-3. Low intensity exercise attenuates the single lipid loading-induced increase in 
mitochondrial H2O2 emitting potential (mEH2O2) during state IV respiration. (A) Muscle 
mEH2O2 in response to lipid based substrates 10mM glycerol-3-phosphate (G3P) + 25µM 
palmitoyl-L-carnitine (PC). G3P stresses the system by feeding electron into Q cycle via 
mitochondrial glycerol-3-phosphate dehydrogenase in the form of FADH2. PC provides 
electrons in the form of NADH and FADH2 via β-oxidation. * p<0.05 vs Control & 
Lipid+Ex. # p<0.05 vs Control. (B) Muscle mEH2O2 in response to complex I reverse 
electron flux by complex II substrate 10mM succinate (S). 10mM G3P was further 
added to provide additional strain. * p<0.05 vs Control. # p<0.05 vs Control & Ex. 
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Figure 2-4. TPP+ (1.5μM) has no affect on mitochondrial respiration but provides high 
TPP+ electrode sensitivity. (A) In PmFBs, a control experiment shows no inhibition of 
mitochondrial respiration by 1.5 µM TPP+ using the same substrate protocol as in figure 
2-5 or figure 2-6 (A). n= 8-10/condition evenly obtain from 2 rats. (B) The TPP+ 
electrode sensitivity obtained from the experiment in figure 2-6 (A) is 53.56±3.034 
mV/Decade (mean±SD, n=36).   
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Figure 2-5. Representative experimental trace of ΔΨm & JO2. Reagents added at the 
start of the experiment include State III respiration ―clamping‖ reagents: 2U/ml 
hexokinase and 5mM 2-deoxyglucose; mitochondrial substrates: 10mM glutamate/ 
15mM pyruvate/ 2mM malate/ 10mM glycerol-3-phosphate/ 10mM succinate. After the 
pTPP+ signal reaches a steady state, the TPP+-selective electrode was calibrated by a 5 
point TPP+ titration range from 1.1 to 1.5µM TPP+. The calibration and sensitivity 
calculation was based on the actual TPP+ working range. PmFBs were added into the 
chamber to obtain the maximal state IV ΔΨm and JO2. An ADP titration (25, 50, 100, 
250, 500, 1000, 2000μM) followed to obtain the kinetics of state III ΔΨm and JO2. 2µM 
FCCP was added in the end to prove the concept that TPP+ uptake is ΔΨm driven. The 
calculated steady state ΔΨm and JO2 is indicated. The experiment was performed at 
25ºC. Blue line: pTPP+. Red line: JO2. Black line: [O2].  
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Figure 2-6. Low intensity exercise attenuates the single lipid loading-induced increase in 
mEH2O2 and reduction in mCa
2+
RC, with increasing JO2 and reducing ΔΨm. To determine if 
low intensity exercise is sufficient to attenuate the potential negative effect on JO2, ΔΨm, 
mEH2O2 and mCa
2+
RC by single lipid loading in skeletal muscle from rats, the kinetics of 
these parameters under state IV-III conditions from PmFBs mitochondria were 
measured. Each experiment was performed essentially in parallel under similar 
buffering conditions supported with the same substrate protocol. 2U/ml hexokinase and 
5mM 2-deoxyglucose were included in the system to ―clamp‖ different level 
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physiological state III respiration states. Multiple substrates including10mM glutamate/ 
15mM pyruvate/ 2mM malate/ 10mM glycerol-3-phosphate/ 10mM succinate were 
added in the beginning of the protocol to obtain a maximal state IV response. An ADP 
titration (25, 50, 100, 250, 500, 1000, 2000µM) followed to obtain the state III kinetics 
response in panel (A) and (B). In panel (C), data from each ADP concentration 
represents each individual experiment/PmFB under the same buffer and substrate 
background as panel (A) and (B). (A) JO2 and ΔΨm. JO2 and ΔΨm were simultaneously 
measured from the same PmFB. Single lipid loading has very little effect on JO2 while 
low intensity exercise causes a mildly increased JO2 across different [ADP] conditions. 
In JO2: * p<0.05 Lipid+Ex vs Control at 0 and 25µM ADP. Slightly increased ΔΨm by 
single lipid loading was normalized by exercise. A less conservative statistics method 
was applied and significance power was set at p<0.05 or p<0.1. ΔΨm at 2000µM was 
not reported since many of the raw pTPP+ signal above 1000µM ADP were not very 
steady and did not meet the steady status criteria. In ΔΨm: $ p<0.05 Lipid vs Lipid+Ex; # 
p<0.1 Lipid vs Lipid+Ex; x p<0.1 Lipid vs control; T-test. (B) Low intensity exercise 
maintain lower mEH2O2 after rats received single lipid loading in both state IV and state III 
condition. * p<0.05 Lipid vs Lipid+Ex. (C) Exercise attenuate the single lipid 
loading-induced reduction in calcium retention capacity under state III but not state IV 
condition. * p<0.05 Lipid vs Control & Ex. Each data set was examed by one-way 
ANOVA + Tukey in each [ADP] condition expect panel (A) ΔΨm data was examed by 
t-test. 
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Figure 2-7. Mitochondrial membrane potential, OXPHOS and H2O2 emission kinetics. 
The control group ΔΨm, JO2 and JH2O2 kinetics data from figure 2-6 was further plotted. 
Mitochondria of permeabilized rat red gastrocnemius muscle was supported by 10mM 
Glutamate/ 15mM Pyruvate/ 2mM Malate/ 10mM Glycerol-3-Phosphate/ 10mM 
Succinate. It was followed by ADP titration. Assays were performed in 25ºC with 25uM 
blebbstatin to prevent muscle contraction and with 2U/ml hexokinase/ 5mM 
2-deoxyglucose/ 20mM creatine to ―clamp‖ the [ADP] level. This proves the concept of 
bioenergetics principle that mild increase in mitochondrial respiration (energy 
expenditure) from idling reduces mitochondrial membrane potential (ΔΨm) and 
exponentially reduces H2O2 emission rate. N = 8.
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Figure 2-8. Schematic illustration showing predicted fluctuations in ΔΨm. (A) An 
individual out of metabolic balance due to excess caloric intake, particularly HFD, and 
sedentary lifestyle. (B) An individual in metabolic balance due to appropriate caloric 
intake and active lifestyle. Dotted line indicates approximate threshold ΔΨm at which 
electrons begin to leak to from superoxide significantly. Arrows signify calorie intake. 
Red indicates progressively increasing mitochondrial H2O2 emission. Blue indicates 
progressively increasing mitochondrial O2 consumption. 
  
 
 
CHAPTER 3: Mildly Increased Energy Expenditure by either Exercise or β-GPA 
Sufficiently Prevent Increased Mitochondrial H2O2 Emission Potential and Insulin 
Resistance Induced by High Fat Diet in Rodents 
 
Abstract 
High fat diet (HFD)-induced mitochondrial H2O2 emission has been suggested as 
a primary factor linking excess fat intake to the development of insulin resistance (IR). 
Mitigating HFD-induced H2O2 emission may be a potential strategy to treat and/or 
prevent type II diabetes. Mitochondrial reactive oxygen species production is favored 
when cellular substrate supply is high and energy demand is low, and vice versa. The 
objective of this study was to determine if a daily mild increase in energy expenditure by 
either low intensity exercise or treatment with β-guanidinopropionic acid (β-GPA), a 
creatine analogue, is sufficient to prevent the increase in skeletal muscle mitochondrial 
H2O2 emitting potential (mEH2O2), and the decrease in insulin sensitivity induced by HFD 
in rodents. HFD increased mEH2O2 and decreased insulin action whereas both were 
preserved by either exercise or β-GPA. The protective effects of exercise or β-GPA 
were independent of mitochondrial respiratory function, fatty acid oxidation rate and 
AMPKα2 genotype. These data demonstrate that a small increase in energy 
expenditure prevents the increase in mEH2O2 potential and development of insulin 
resistance, supporting the concept that the governance of mitochondrial H2O2 emission 
is a primary factor regulating insulin sensitivity in skeletal muscle. 
 
Introduction 
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A considerable body of research has reported consistent elevations in oxidative 
stress in both animal and human models of obesity and type II diabetes (T2D)21,63,64,224. 
Furthermore, a cause and effect relationship between mitochondrial reactive oxygen 
species (ROS) production and insulin resistance (IR) has recently been suggested62-65. 
In this context, mitigating oxidative stress may be a potential strategy to treat and/or 
prevent diabetes. Disruptions in whole body metabolic balance, in which substrate 
supply far exceeds energy demand on a consistent basis is believed to be the driving 
force behind this aforementioned relationship between mitochondrial ROS and 
metabolic disease. Previous work by our group has demonstrated that acute and 
chronic nutritional oversupply increases muscle mitochondrial H2O2 emitting potential 
(mEH2O2), a phenomenon that is causally linked to IR
64. The interplay between metabolic 
supply and ROS production is well established, yet the extent to which energy 
expenditure can compensate for the deleterious effects of over-nutrition on ROS 
production, cellular redox state and insulin sensitivity is currently unknown. Based on 
fundamental principles of bioenergetics, when the rate of ADP supply to mitochondria is 
very low (state IV or close to state IV respiration), the mitochondrial membrane potential 
(ΔΨm) is high and an exponential increase in superoxide (O2¯•) generation occurs within 
a small range of ΔΨm values exceeding about -160mV
79,81-84. The inverse occurs when 
the mitochondrial ADP levels rise (i.e., ↑energy turnover or ↑energy expenditure) which 
lead to a reduction in ΔΨm through F1F0 ATP synthase complex activity
85,86 and 
dramatically reduced O2¯• generation. Therefore, increased energy expenditure 
(↑ADP/ATP) or reduced substrate supply (↓NADH/NAD+) can reduce O2¯• generation, 
decrease oxidative damage, and potentially attenuate IR. Therefore, we hypothesized 
that chronic mild increases in energy expenditure by either low intensity exercise or 
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β-guanidinopropionic acid (β-GPA) treatment could sufficiently prevent the increase in 
mitochondrial oxidant emitting potential and the decrease in insulin sensitivity that is 
normally induced by a high fat diet (HFD). 
Increasing physical activity represents one of the most effective means of 
reversing IR in skeletal muscle of overweight/obese patients at high risk for T2D. 
However, it is generally believed that moderate-high intensity aerobic exercise is 
required to have a positive outcome on IR. However, if oxidative stress is a primary 
factor causing insulin resistance, then even a mild increase in energy expenditure 
should be sufficient to prevent diet induced IR as it should, in theory, reduce O2¯• 
generation significantly. 
β-GPA is a non-metabolized creatine analog that cannot be used to regenerate 
ATP. β-GPA feeding in rodents chronically decreases skeletal muscle ATP, 
phosphocreatine, creatine and total creatine content by about 50%, 90%, 80% and 85%, 
respectively185. In other words, cellular energy charge is decreased, which causes an 
increase in cellular metabolic demand (ATP synthesis) to compensate for the decrease 
in energy availability. Consistent with work showing an increase in mitochondrial 
biogenesis during conditions of high metabolic demand, β-GPA feeding has also been 
shown to induce mitochondrial biogenesis in rodent skeletal muscle189,258, while 
attenuating IR and T2D182-184 although the exact mechanism is unclear. The overriding 
hypothesis of this project is that a mild increase in energy expenditure in cells will 
significantly decrease mEH2O2 and thereby prevent the development of IR induced by a 
HFD. However, an increase in energy expenditure and associated decrease intracellular 
energy charge (i.e., ATP/ADP ratio) may also activate 5‘-AMP-activated protein kinase 
(AMPK). AMPK-mediated signaling is known to stimulate glucose uptake independent 
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of insulin192. Both exercise186-188 and β-GPA185,189-191 have also been shown to activate 
AMPK. This suggests any metabolic effects induced by exercise or β-GPA, if occurring, 
may be mediated by AMPK and/or mH2O2. AMPKα2 is the main AMPK catalytic subunit 
dominant in skeletal muscle, heart, and liver259-261. Therefore, to better define the role of 
AMPKα2 signaling under β-GPA feeding, we tested whether β-GPA treatment 
normalized HFD induced IR and elevated mEH2O2 in the AMPKα2-DN mice. The 
AMPKα2-DN mice262 express a dominant negative mutant (non-functional) form of the 
AMPK alpha2 catalytic subunit specifically in both skeletal and cardiac muscle.  
The results show that a daily mild increase in energy expenditure, independent of 
AMPK activation, is sufficient to prevent the increase in skeletal muscle mEH2O2, and 
decrease in insulin sensitivity induced by metabolic oversupply (HFD). 
 
Methods 
Rat Study 
Young male Sprague-Dawley rats (4 groups, n=10/ group, ~200g bodyweight) 
were maintained on a standard 12h/12h light/dark cycle (7:00 am light). Rats were fed a 
standard chow (Chow) or high fat diet (HF, rodent diet with 60% of total calorie from fat, 
Research Diets D12492) for seven weeks. The animals given a high fat diet were also 
administered either low intensity exercise (HF-EX, treadmill, 15m/min, 0 grade, 2h/d, 
3-5pm, 7d/wk, 7wks) or β-GPA (HF-GPA, 2 times of 200mg/kg whole body mass/day, 
8:30am & 5:00pm, 7d/wk, the final 5 wks only, by oral gavage). β-GPA was 
administered twice a day to account for the metabolic clearance. A water gavage (1ml) 
control was performed in Chow, HF and HF-EX groups every 3 days. Body weight was 
recorded weekly. The rats were acclimated to procedure conditions every 2 weeks 
 - 59 - 
 
including restraining/handling. A 10h fasting blood sample from the tail vain followed for 
blood glucose and serum insulin level determination. There was no difference in fasting 
glucose and insulin level over the time course of treatment or between groups (data not 
shown). Oral glucose tolerance tests (OGTT, 2g/ kg whole body mass) were conducted 
during week 6 in the morning following an overnight fast (10h). Blood samples from 
OGTT were analyzed for glucose using a handheld glucometer (OneTouch Ultra) and 
serum insulin levels using a commercially available ELISA kit (Millipore). In the morning 
during week 7, five rats from each group were sacrificed after either a 4h fast (n=5/ 
group) or 1h after a glucose gavage (2g/ kg whole body mass) performed after a 3h fast 
to examine mitochondrial function, oxidative stress and insulin signaling in muscle.  
Insulin sensitivity index was calculated as the inverse of the area under the curve for 
glucose x area under the curve for insulin263. Muscle fiber samples from fresh red 
gastrocnemius (RG) were obtained and trimmed of connective tissue. A portion of 
muscle (~20mg) was immediately used for the preparation of small fiber bundles (each 
~0.8-1.5mg wet weight, ~100 muscle fibers/bundle) under a dissecting scope. Fiber 
bundles were immediately saponin-permeabilized and maintained in buffer at 4ºC until 
used to assess mitochondrial oxygen respiration (JO2) and mEH2O2. Fresh mixed 
gastrocnemius muscle and liver tissue were also obtained to determine FAO rate. The 
remainder of the fresh RG was frozen by liquid nitrogen and stored in -80oC for later 
analysis of AMPK and insulin signaling proteins (total and phosphorylated AMPKThr172 
and AktSer473 by Western Blot).  
AMPKα2-DN Mouse Study 
AMPKα2-DN mice were kindly provided by Morris Birnbaum262. Male 
AMPKα2-DN mice and their wild-type (WT) littermates (5 groups, n=9-18/group) were 
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fed standard chow diet or HFD with or without β-GPA started at 13-18 weeks of age. 
Mice were maintained on a standard 12h/12h light/dark cycle (7:00 am light). WT mice 
were fed standard chow (WT-Chow) or HFD for 10 weeks (Research Diets D12492) 
(WT-HF), or HFD plus β-GPA oral gavage for 10 weeks (WT-HF-GPA, 2 times of 
250mg/ kg whole body mass/day, 8:30am & 5:00pm, 7d/wk). AMPKα2-DN mice were 
fed HFD for 10 weeks (DN-HF), or HFD plus β-GPA oral gavage for 10 weeks 
(DN-HF-GPA). A water gavage (0.4ml) was performed on all non-β-GPA fed groups 
every 3 days. Body weight was recorded weekly. In week 8, whole body metabolic state 
was assessed via an indirect calorimetry system. Body composition was determined 
immediately after the mice came out of the calorimetry system. In week 9, after the mice 
acclimated to surgery room and restrainers/handling for 2 days, intraperitoneal glucose 
tolerance tests (IPGTT, 1.5g dextrose/kg whole body mass) were performed following a 
4h fast that began at 4:00 am (last 3h of dark cycle). Blood samples from the IPGTT 
were analyzed for blood glucose and plasma insulin level (fasting and 30 minutes after 
the glucose injection). Mice were sacrificed on the 10th week after a 4h fast in the 
morning. Soleus & EDL muscle strips from both legs were obtained for the 
measurement of basal and insulin stimulated 3H-2-deoxyglucose (3H-2-DOG) uptake. A 
portion of fresh RG was immediately saponin-permeabilized and maintained (4ºC) in 
buffer for the determination of JO2 and mEH2O2. Body composition was determined again 
the day prior to sacrifice. 
Permeabilized Myofibers (PmFBs) Preparation 
Animals were anaesthetized by IP injection of ketamine/xylazine (9:1) mixture. 
The same portion of fresh RG muscle from each animal was harvested, trimmed of 
connective tissue, and fresh muscle ﬁber bundles (~2 x 7mm, 2-3mg wet weight) were 
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gently separated to maximize the exposure surface using ﬁne forceps under a binocular 
dissecting microscope in ice-cold buffer X containing (in mM) 60 K-MES, 35 KCl, 7.23 
K2EGTA, 2.77 CaK2EGTA, 20 imidazole, 0.5 dithiothreitol, 20 taurine, 5.7 ATP, 15 
phosphocreatine 6.56 MgCl2·6H2O (pH adjusted to 7.10) plus 0.5 glutamate (G) and 0.2 
malate (M). After separation, the plasma membrane of myoﬁber bundles were 
permeabilized in buffer X with 0.5mM G, 0.2mM M and 50μg/ml saponin while gently 
shaking on a rocker at 4ºC for 30min. To wash out the extra-mitochondrial components, 
the PmFBs were subsequently washed in buffer Z containing (in mM) 105 K-Mes, 30 
KCl, 10 K2HPO4, 5 MgCl2·6H2O and 5mg/ml bovine serum albumin (pH adjusted to 
7.40) plus freshly added 1 EGTA, 0.5 G and 0.2 M with gently shaking on a rocker at 
4ºC for 15 min. 
Measuring JO2 in PmFBs 
JO2 was measured in PmFBs (~0.4mg after freeze-dried) using high-resolution 
respirometry (Oroboros Oxygraph-2 K (O2K) Innsbruck, Austria) at 30ºC in assay buffer 
containing buffer Z plus 1mM EGTA, 20mM creatine (to saturate endogenous creatine 
kinase) and 50µM N-benzyl-p-toluene sulphonamide (a muscle contraction inhibitor264). 
After establishing a background JO2 rate in the presence of a PmFB, the reaction was 
initiated by the addition of sequential substrates. 
Measuring mEH2O2 in PmFBs  
Washed PmFBs (~0.2mg after freeze-dried) were rinsed with 10mM sodium 
pyrophosphate in ice-cold Buffer Z for three minutes prior to mEH2O2 measuring to 
deplete the fibers of endogenous adenine nucleotides and to prevent 
calcium-independent contraction of the fibers during the assay. mEH2O2 was measured 
by continuously monitoring the fluorescence probe Amplex Red (Invitrogen, A22188; 
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excitation/emission: 563/587nm) using spectroﬂuorometers (In rat study: Spex 
Fluoromax 3, Horiba Jobin Yvon; in mice study: Fluorolog-3, Horiba Jobin Yvon) with 
temperature control at 30ºC and magnetic stirring. The assay buffer contained buffer Z 
plus 10U/ml CuZn-superoxide dismutase, 10µM Amplex Red, 1.5U/ml horseradish 
peroxidase and 10µg/ml oligomycin (state IV respiration condition). After establishing a 
background fluorescence rate in the presence of a PmFB, the experiment was initiated 
by the addition of sequential substrates. mEH2O2 rate was calculated from the slope of 
ΔF/min, after subtracting background, using a standard curve established for each 
reaction condition. 
At the conclusion of each experiment, PmFBs were washed in ddH2O to remove 
salts and then freeze-dried in a lyophilizer (LabConco). JO2 and mEH2O2 were normalized 
to dry tissue weight since a functional index of mitochondria density (FCCP uncoupled 
JO2, figure 3-4, 3-5 (non glucose challenged state) & figure 3-12) was not significantly 
different between groups in either rat or mouse study. 
Indirect Calorimetry and Locomotor Activity 
Mouse whole body metabolic state at week 8 of treatment was measured in a 
Calorimetry Module (CaloSys V2.1, TSE Systems) with the relevant software (ActiMot2, 
TSE Systems) for two complete light-dark cycles (48h) after 4 days of acclimation. 
Parameters measured included whole body oxygen consumption, CO2 expiration, 
respiratory exchange ratio (RER), food intake and X+Y+Z axis locomotor activity. 
Body Composition 
Whole body composition of live mice was determined using the Echo Magnetic 
Resonance Imaging (EchoMRI-900™, Echo Medical System, Houston, TX), a QNMR 
system used to precisely measure whole body composition parameters including total 
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body fat, lean mass, body fluids, and total body water in live rats/mice without the need 
for anesthesia or sedation. 
3H-2-DOG Uptake 
Muscle strip 3H-2-DOG uptake assay was modified from previously described 
methods265,266. Immediately after excision from the animal, muscle samples were placed 
in a sealed container with 1.5ml of oxygenated (95% O2 & 5% CO2) Krebs-Henseleit 
buffer (KHB), containing (mM): 2.52 CaCl2, 4.73 KCl, 1.18 MgSO4, 118 NaCl, 1.17 
KH2PO4 and 25 NaHCO3 with 25µM blebbistatin (Bleb, an inhibitor of  myosin II 
crossbridge formation212-215) in room temperature for transport. Each experiment was 60 
min in total duration. Muscle strips were ﬁrst pre-incubated for 30min under basal 
conditions (oxygenated KHB+Bleb). Where appropriate, muscle strips were 
pre-incubated with insulin (100nM) for the last 10min of this pre-incubation period. 
Following the pre-incubation period, muscle strips were then transferred to incubation 
wells containing identical conditions with the exception that the incubation media 
contained 10mM 2-DOG, 40mM mannitol, 2.0µCi/ml 3H-2-DOG (to quantify glucose 
transport), 0.1µCi/ml 14C-D-mannitol (as an extracellular space marker), and with or 
without insulin (100nM) where appropriate. Pre-incubation and incubation volumes were 
2ml. Samples were continuously gassed with 95% O2 & 5% CO2. Incubation 
temperature was maintained at 29ºC in a gentle shaking water bath. After incubation 
period, muscle strips were washed in ice-cold KHB gently twice for 5 minutes each to 
wash off excess 2-DOG and mannitol from the samples. After washing, muscle strips 
were blotted, weighed, and then solubilized in 0.5ml of 0.5N NaOH. Solubilized muscle 
strips and incubation media samples (speciﬁc activity determination) were then 
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stabilized in scintillation fluid for 7 days before being counted in a Beckman LS 5000 TD 
liquid scintillation counter preset to count 14C and 3H channels simultaneously. 
Preparation of Skeletal Muscle Homogenates and Western Blotting 
Frozen muscles were powdered under liquid N2 and 50-80mg of powdered tissue 
was homogenized in ice-cold lysis buffer [50mM HEPES, 50mM Na+ pyrophosphate, 
100mM Na+ fluoride, 10mM EDTA, 10mM Na+ orthovanadate, 1% Triton X-100, and 
protease and phosphatase (1 and 2) inhibitor cocktails (Sigma, St. Louis, MO)]. 
Homogenates were sonicated for 10sec then rotated for 2h at 4ºC. After centrifugation 
for 25min at 15,000g, supernatants were extracted and protein content was detected 
using a BCA protein assay (Pierce, Rockford, IL) and individual homogenate volumes 
were separated into 50µg of protein before being frozen in liquid nitrogen and stored at 
-80ºC until used for immunoblotting. Conventional immunoblotting techniques were 
employed using antibodies specific for total AMPK, phosphorylated AMPKThr172, total Akt 
and phosphorylated AktSer473 (Cell Signaling 2532, 2531, 9272 and 9271, respectively). 
Homogenates were subjected to monoclonal IP antibody overnight then coupled to 
protein A sepharose beads and rotated for 2 hours (Amersham Biosciences, Uppsala 
Sweden) and eluted with sample buffer. Samples were separated by SDS-PAGE using 
7.5% or 10% Tris-HCl gels and then transferred to PVDF membranes for probing by 
appropriate antibodies. Following incubation with primary antibodies, blots were 
incubated with appropriate horseradish peroxidase-conjugated secondary antibodies. 
Horseradish peroxidase activity was assessed with ECL solution (Thermo Scientific, 
Rockford, IL), and exposed to film. The image was scanned and band densitometry was 
assessed with Gel Pro Analyzer software (Media Cybernetics, Silver Spring, MD). 
Content of phospho-proteins (using phosphor-specific antibodies) was calculated from 
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the density of the band of the phospho-protein divided by the density of the protein 
using the appropriate antibody. 
Muscle and Liver Fatty Acid Oxidation 
With minor modiﬁcations from previous267, experiment utilizing [1-14C]palmitate 
was performed to study the mitochondrial fatty acid oxidation rate of fresh liver and 
mixed gastrocnemius muscle tissue homogenate. Palmitate (200µM) was bound to 
0.5% bovine serum albumin (3.3 molar ratio of fatty acid:albumin). Specific activities for 
[1-14C]palmitate (200µM) were ~8,000-10,000dpm/nmol (0.5µCi/ml). Once solubilized, 
fatty acid substrate were brought up in reaction buffer to yield the following final 
concentrations (mM): 100 sucrose, 10 Tris·HCl, 10 KPO4, 100 KCl, 1 MgCl2·6H2O, 1 
L-carnitine, 0.1 malate, 2 ATP, 0.05 coenzyme A, and 1 dithiothreitol (pH adjusted to 
7.40). Oxidation studies measured 14C-labeled CO2 and acid-soluble metabolite (ASM) 
production over the course of 30 min. Radioactivity of CO2 and ASM fractions was 
determined by liquid scintillation counting using 4ml of Uniscint BD (National 
Diagnostics, Atlanta, GA). Fatty acid oxidation was quantified using the following 
formula: 60 min/h x [(dpm – BL)/SA]/[g of tissue wet wt/well x time (min) of reaction 
incubation], where BL is dpm of blank wells and SA is fatty acid-specific radioactivity. 
Data are expressed as nano moles of substrate oxidized per gram tissue wet weight per 
hour. 
Statistical Analysis 
A monoexponential fitting of the Michaelis-Menten kinetic curve was computed 
using GraphPad Prism software 5.02 (San Diego, CA) to determine the Km and Vmax 
of the respirometric substrate titration data. Independent student‘s t-tests, one way 
ANOVA + Tukey or two-way ANOVA + Bonferroni (as appropriate) were performed as 
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dictated by the design of the study. All values are reported as Mean ± SEM. Statistical 
significance was set at p<0.05. 
  
Results 
HFD-Induced Insulin Resistance is Attenuated by β-GPA and Exercise in Rats 
Independent of Changes in Fatty Acid Oxidation 
Body weight increased over the duration of the study but did not differ among 
treatment groups (Fig. 3-1F). To determine if daily treatment with β-GPA or low intensity 
daily treadmill exercise is sufficient to preserve insulin action in rats consuming a HFD, 
whole body glucose tolerance and skeletal muscle insulin signaling were measured. As 
expected, the areas under the curve for both glucose and insulin were elevated in 
HFD-fed rats. Both β-GPA treatment and exercise preserved whole body insulin 
sensitivity (Fig. 3-1A-E). Interestingly, the increase in Akt phosphorylation, a marker of 
insulin signaling, 1h following a glucose challenge was blunted in animals fed the HFD, 
consistent with the development of insulin resistance. However, Akt phosphorylation 
was partially restored only in the β-GPA treated animals (Fig. 3-2A). Interestingly, the 
improved glucose clearance in the β-GPA-, but not low intensity exercise-, treated 
animals occurred concurrent with increased AMPK phosphorylation ratio, an index of 
AMPK activation (Fig. 3-2B). To determine if potential treatment effects on insulin 
sensitivity paralleled changes in FAO, palmitate oxidation was measured from fresh 
mixed gastrocnemius muscle and liver tissue homogenates. HFD did not cause any 
change in FAO in either skeletal muscle or liver homogenates. In fact, a trend of 
increased FAO in HFD fed rats was observed in muscle (Fig. 3-3). 
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β-GPA and Exercise Improve Mitochondrial OXPHOS Capacity in Rats 
To determine if HFD alone or coupled with daily β-GPA treatment or low intensity 
exercise alters mitochondrial respiratory sensitivity and capacity, JO2 in PmFBs was 
assessed under both basal (4h fast) and 1h after glucose challenge. Mitochondrial 
respiratory control indices which indicate the quality of mitochondria OXPHOS capacity 
were also calculated. During respiration supported only by the complex I substrates 
glutamate + malate, no differences were detected in either mitochondrial respiratory 
sensitivity or capacity under basal (no glucose challenge) or glucose challenge 
conditions with the exception of a decrease in sensitivity to ADP (increased Km) in 
HF-GPA rats in the basal state (Fig. 3-4). During respiration supported by multiple 
substrates, maximal ADP-stimulated respiration was increased by HF-GPA in the basal 
condition. Interestingly, in the glucose challenged condition, maximal respiration was 
elevated by HFD treatment and further elevated in HF-GPA and HF-EX (Fig. 3-5). The 
mitochondrial respiratory control indices showed no treatment effect on the ADP titration 
protocol in both basal and glucose challenged states or basal states using multiple 
substrates (Fig. 3-6). Under glucose challenged state in multiple substrate condition, 
HFD induced improvements in both respiration control ratio (increased) and adenylate 
control ratio (decreased) independent of β-GPA or exercise treatment (Fig. 3-6F). 
β-GPA and Exercise Prevent HFD-Induced mEH2O2 and mFRL% in Rats 
To determine if daily treatment with β-GPA or low intensity exercise may 
attenuate or prevent HFD induced elevations in mEH2O2
64, mEH2O2 was assessed under 
both basal and glucose challenge conditions. During succinate-supported respiration 
which induces high rates of H2O2 emission due to reverse electron flux back through 
complex I, HFD-induced a >2-fold increase in mEH2O2 under basal conditions that was 
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prevented by both β-GPA and exercise treatments (Fig. 3-7). Nearly identical responses, 
including protection by β-GPA and exercise treatments, were seen during respiration 
supported by multiple substrates (Fig. 3-8). In the glucose challenged condition, mEH2O2 
was increased in the chow fed animals during both succinate and multi-substrate 
conditions, illustrating the acute impact of metabolic overload on mitochondrial H2O2 
emission. Mitochondrial free radical leak percentage (mFRL%), an index of H2O2 
emission per O2 consumed, was also increased in HF animals and in chow fed animals 
in response to the glucose challenge (Fig. 3-9). Interestingly, the glucose challenge did 
not induce a further increase in mFRL% in HF animals, implying a ceiling effect. Both 
β-GPA and exercise treatments prevented the HFD-induced increase mFRL% in both 
the basal and glucose challenge conditions.  
β-GPA effects on Body Composition, Metabolic State and Locomotor Activity in Mice 
are independent of AMPKα2 Genotype 
To further test whether improvements in whole body metabolic profile, cellular 
oxidative stress and insulin sensitivity in response to β-GPA treatment during a HFD 
may be mediated by AMPK (suggested in Fig. 3-2B), young male AMPKα2-DN and their 
wild-type (WT) littermates were fed a HFD with or without β-GPA. The whole body 
metabolic state of these mice was monitored. Regardless of AMPKα2 genotype, β-GPA 
prevented HFD-induced body weight gain while both food intake and energy 
expenditure were significantly increased (Fig. 3-10). Importantly, total locomotor activity 
was not affected by β-GPA treatment, indicating that the increase in energy expenditure 
with β-GPA treatment was likely due to an increase in basal oxidative metabolism due 
to creatine depletion. Furthermore, respiratory exchange ratio was lower in β-GPA fed 
mice indicating a greater reliance on lipid metabolism. All metabolic parameters were 
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normalized to lean body mass to eliminate bias introduced by differences in total body 
weight between groups.  
β-GPA Maintains Insulin Sensitivity in Mice Fed a HFD Independent of AMPKα2 
Genotype 
IPGTT and muscle 3H-2-DOG uptake were conducted to determine if the effects 
of β-GPA on insulin sensitivity may be mediated by AMPK (Fig. 3-11). β-GPA treatment 
completely normalized both whole body glucose and insulin responses to the IPGTT 
and muscle-specific insulin-stimulated glucose uptake rates regardless of AMPKα2 
genotype. These findings indicate that the protective effects of β-GPA on HFD-induced 
insulin resistance are not mediated by AMPKα2. Interestingly, insulin-stimulated glucose 
uptake was higher in the EDL muscle of HF β-GPA treated as compared with chow fed 
wild-type mice. 
β-GPA Prevents HFD-Induced mEH2O2 and mFRL% Regardless of AMPKα2 Genotype 
As expected, HFD significantly increased mEH2O2 under multiple substrate 
conditions (Fig. 3-12). By contrast, neither mitochondrial respiratory capacity nor various 
indices of respiratory control were affected by the dietary regimen (Fig. 3-12 and 3-13), 
indicating ―normal‖ mitochondrial respiratory function. Regardless of AMPKα2 genotype, 
β-GPA treatment completely prevented the HFD-induced increase in mEH2O2 and 
mFRL% (Fig. 3-12), again in the absence of any change in respiratory function. In fact, 
β-GPA treated mice on HFD displayed lower mEH2O2 and mFRL% compared with the 
standard chow diet fed mice.   
 
Discussion 
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In the present study, chronic elevations in energy expenditure by either low 
intensity exercise or β-GPA treatment in both rats and AMPKα2-DN mice, resulted in 
the following major findings. First, aside from conventional wisdom that moderate-high 
energy expenditure is required, our results indicate a mild increase in energy demand 
by daily low intensity exercise or β-GPA treatment is sufficient to attenuate the 
HFD-induced mEH2O2 and IR. It follows from the principles of bioenergetics that a small 
reduction in ΔΨm caused by a mild increase in respiration from idling (close to state IV 
respiration condition) can sufficiently lower ―the reducing pressure of electron transport 
system (ETS)‖ and oxidant production that is otherwise causally linked to IR. Second, 
these data provide further support for the idea that elevated mitochondrial mEH2O2 
(and/or downstream oxidative stress) is likely to be one of the primary factors 
contributing to HFD-induced IR. Importantly, these findings demonstrate that the 
protective effects induced by an increase in energy expenditure are not mediated by 
activation of AMPKα2. Third, skeletal muscle mEH2O2 and mFRL%, but not OXPHOS 
capacity, are acutely sensitive to metabolic state. Glucose loading caused a 30~108% 
increase in mEH2O2 and mFRL%, even in chow fed rats. Acute glucose loading however 
did not further increase mEH2O2 and mFRL% in HF fed animals, providing evidence of a 
ceiling effect of metabolic overload on factors governing mitochondrial oxidant emission. 
Collectively, these findings provide clear evidence that metabolic oversupply induces 
elevated mEH2O2 and IR while the other side of the balance equation, energy expenditure, 
reduces both. These findings are consistent with the hypothesis that mitochondrial 
H2O2 production is very sensitive to cellular metabolic state, the emission of which 
under metabolic overload is at least one of the preceding/primary factors ultimately 
leading to IR. The balance of substrate supply and energy expenditure is critical for 
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maintaining proper cellular redox environment and therefore cellular function and whole 
body health. 
The benefits of regular moderate-high intensity aerobic exercise on metabolic 
diseases, as well as mitochondria related effects, are well known. The higher the 
aerobic exercise intensity, the greater the adaptive response (e.g. cardiovascular 
adaptation). However, the idea that a threshold level of activity may exert a protective 
effect against metabolic imbalance has not been previously explored. A ―minimal‖ 
mitochondrial respiratory activity stimulus was selected by the design in the present 
study based on the bioenergetics principle that only a slight increase in mitochondria 
respiratory activity from idling should be sufficient to alleviate the pressure leading to 
elevated mitochondrial H2O2 emission caused by HFD-induced metabolic overload. Our 
data show that only a mild increase in energy expenditure is sufficient to prevent the 
development of insulin resistance in the setting of a HFD. This protective effect occurred 
with minimal increase in energy expenditure, as none of the adaptations typically 
associated regular higher intensity exercise training (e.g., mitochondrial biogenesis, 
cardiovascular adaptations, etc.) were found. However, whether the mEH2O2 change was 
contributed by the treatment effect on mitochondrial oxidant production and/or 
anti-oxidant scavenging/buffering system (i.e., GSH/GSSG, thioredoxin and others) is 
unknown although it was shown that HFD reduce skeletal muscle GSH/GSSG ratio 
acutely and chronically64,268. 
β-GPA is an antidiabetic/antihyperglycemic agent182-184 with unclear mechanism. 
In a dose and duration dependent manner, β-GPA induces a chronic reduction in 
cellular energy level and therefore activation of AMPK which is thought in turn to 
coordinate the activation of catabolic pathways and inactivation of anabolic pathways, 
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as well as activate pathways leading to the transcriptional activation of mitochondria 
biogenesis. These same effects were believed to mediate the improvements in insulin 
sensitivity induced by β-GPA182-184. However, many of these observations were from 
animals fed with 1~2% of β-GPA in the diet. Since eating behavior can potentially be 
changed by the drug, it is difficult to evaluate the effective β-GPA dose and its potential 
relationship to the metabolic outcomes in these studies. In the present study, β-GPA 
was administered by oral gavage, thus insuring stable and consistent dosing. Our data 
show in mice β-GPA treatment caused an increase in energy expenditure and 
compensatory increase in food intake despite no change in locomotor activity or 
HFD-induced weight gain, providing evidence of a decrease in metabolic efficiency as a 
consequence of the treatment. These findings are therefore consistent with the 
interpretation that β-GPA accelerated energy synthesizing demand in muscle, thereby 
relieving the elevated mitochondrial reducing pressure and mEH2O2 created by a HFD. 
However, β-GPA treatment also elicited an increase in muscle AMPKα2 activity, raising 
the possible alternative interpretation that the protective effects of the drug may be 
mediated simply by the activation of this energy sensing kinase. AMPKα2 is well known 
to stimulate muscle glucose uptake. However, when repeated in AMPKα2-DN mice, 
β-GPA treatment protected against the HFD-induced increase in mEH2O2 and loss of 
insulin sensitivity in both AMPKα2-DN and wild-type mice, suggesting the effects of 
β-GPA are not mediated by AMPKα2 activation. However, we cannot exclude a 
potential compensatory increase in AMPKα1 activity in response to β-GPA treatment. In 
a different muscle-specific AMPKα2-DN line of mice however, no compensatory 
increase in α1 was found under either basal or 
5-aminoimidazole-4-carboxamide-ribonucleoside (AICAR) -stimulated conditions269.  
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β-GPA also activates mitochondrial biogenesis, and an increase in mitochondrial 
content could account for an increase in basal energy requirements and thus energy 
expenditure. However, β-GPA treatment increased OXPHOS capacity in the rat study 
but not in the mouse study while both mice and rats were protected from HFD-induced 
IR. We also found no clear increase in the functional index of mitochondrial content 
(FCCP uncoupled respiration) in both mice and rats treated with β-GPA. Similarly, low 
intensity exercise maintained the insulin sensitivity under the HFD condition without an 
increase AMPK phosphorylation ratio or consistent increase in OXPHOS capacity. Thus, 
neither AMPK activity nor OXPHOS/mitochondrial content tracked consistently with 
insulin sensitivity in both rat and mouse studies. In contrast, the increase in energy 
expenditure and decreases in mEH2O2 and mFRL% induced by β-GPA treatment, in the 
absence of any change in locomotor activity, consistently tracked with protection from 
HFD-induced insulin resistance. Although these findings cannot establish cause and 
effect, they support the concept that mitochondrial H2O2 is a major sensor of 
intracellular energy balance and a primary signal regulating insulin sensitivity64.  
Studies in which reduced FAO rates or mitochondrial OXPHOS capacity 
observed in muscle from elderly individuals, family offspring of diabetics, or 
obese/diabetic have been interpreted as indicative of a diminished FAO capacity17,18,23. 
The diminished FAO or OXPHOS capacity has been suggested to be a primary cause 
of IR due to the inappropriate cellular lipid accumulation which activates DAG-PKC-IRS 
pathway and results in the blockage of insulin signaling cascade8,9,11,17,270. Evidence for 
reduced mitochondrial function has been shown to associate with long-term substrate 
oversupply such as occurs with IR or T2D19-22. These include reduced mitochondrial 
content23, size23, enzyme activity24-26, ETS complexes and OXPHOS activity or 
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respiration16,17,27,28, TCA cycle flux rates29, ATP production25,26, and decreased 
expression of OXPHOS related genes15,30,31. However in the present study, IR was 
induced by 7-10 weeks of HFD in rodents in the absence of any change in mitochondrial 
FAO/OXPHOS capacity. It should be appreciated that mitochondrial H2O2 production 
and emission are extremely sensitive to acute metabolic balance as evidenced by the 
impact of acute glucose ingestion on mEH2O2 and GSH/GSSG ratios in muscle (Fig. 3-7, 
3-8 and Anderson et al64). Elevated mEH2O2 and consequent shifting to a more oxidized 
redox environment has been linked to development of IR and, under persistent 
metabolic oversupply states, is likely contributing to mitochondrial OXPHOS deficiencies 
and eventual mitoptosis63. 
Mounting evidence also suggests that mitochondrial dysfunction represents a 
secondary event in the development of IR or T2D35-37,63,64. Reports from animal and 
human studies have shown long-term HFD may not affect38-40,64 or may even 
promote41-45 skeletal muscle mitochondrial function while IR may already exist. Although 
oversupply of fuel can over-ride mitochondrial compensation19, short-term or early stage 
HFD feeding could actually promote mitochondrial density and FAO activity due to a 
prompt adaptive response19,42,44,51. Our data support this idea in which significantly 
reduced FAO and mitochondrial OXPHOS capacity are unlikely the only primary cause 
of over-nutrition induced IR. In fact, a decrease in mitochondrial function observed in 
insulin-resistant humans may not even limit muscle FAO and lead to lipid 
accumulation22. It is of importance to recognize the muscle mitochondrial 
FAO/OXPHOS capacity, such as during maximal exercise, is far in excess of the rate 
measured under resting conditions when energy demand, and thus the rate of 
FAO/OXPHOS, is low. In other words, it is questionable whether mitochondrial 
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FAO/OXPHOS deficiencies would have a considerable limitation on the rate of 
FAO/OXPHOS under normal resting conditions when energy demand is low22. In this 
context, the imbalance of substrate supply and consumption capacity (i.e., energy 
demand) of mitochondria should be the primary factor leading to IR and lipid 
accumulation. Most importantly, and perhaps most germane, it is imperative to 
recognize that the rate of mitochondrial respiration (i.e., oxidative metabolism) in cells is 
governed mainly by energy demand (basal + ADP-driven)52,53. Thus, based on 
principles of mitochondrial bioenergetics, intramyocellular lipid accumulation will occur 
whenever the supply of lipids exceeds the energy needs of the cell, independent of 
mitochondrial content or capacity. A reduction in mitochondrial density, if it does occur, 
will reduce overall basal non-ADP driven state IV respiration (i.e., basal energy demand) 
since mitochondria account for approximately 25% of basal metabolic rate54,55, but the 
underlying mechanism accounting for lipid accumulation is still supply outpacing 
demand. 
Compelling evidence is also accumulating to suggest a cause and effect 
relationship between mitochondrial H2O2 emission/oxidative stress and IR
62-65. However, 
the detailed molecular pathway as to how ROS leads to IR is still largely unknown. 
Other than causing oxidative damage (e.g., lipids, proteins or DNA), what is the 
mechanism makes signaling pathways redox-sensitive and insulin sensitivity potentially 
redox-regulated? Both mitochondrial proteins and insulin signaling proteins appear to be 
regulated by redox-sensitive protein modification which alters protein activity/function. 
Redox regulation of cell function is mainly mediated by thiol (-SH) redox circuits, which 
normally reversibly control the intracellular localization and activity of many cell 
signaling and physiological regulation proteins90,105,114,115. Protein thiols are rich in 
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mitochondrial ETS proteins271,272 and the reactive/regulatory protein thiols that are 
believed to have physiological functions are mainly found within complex I273-277. 
Oxidative stress causes multiple types of redox-sensitive protein modifications in 
complex I proteins274,276-278. This could further lead to complex I O2¯• production 
increase276,279 and oxidative activity reduction274,278,279. These data raise the possibility 
that the metabolic oversupply induced increase in mEH2O2 may be related to a change of 
redox state of mitochondria proteins in a vicious cycle manner. Further, oxidation of 
some insulin signaling proteins might lead to suppression of insulin signaling. These 
proteins include IRS121-124, Ras125, PI3 kinase130, PKC and Akt (PKB). Many PKC 
isoforms appear to be sensitive to redox inhibition by S-glutathionylation or unknown 
protein modification114,126-128. Purified human recombinant aPKC-ζ is subject to oxidative 
inactivation by S-glutathiolation induced by the concentration-dependent thiol-specific 
oxidant diamide, which induces disulfide bridge formation129. In addition, H2O2 exposure 
results in impaired Akt activation131,132, while lipoic acid, by its capacity to maintain 
intracellular redox state, protects against oxidative stress induced impairment in Akt 
activity133. Akt is reversibly inactivated by S-nitrosylation135 specifically in Cys224136 or 
Cys296137. Nevertheless, sirtuin 1176, a key protein involved in metabolism, is also 
redox-sensitive although no direct evidence has shown active site specific 
redox-sensitive cysteine residues yet. Together, the redox-sensitive protein modification 
mechanism of IR is circumstantially compelling. However, most of the redox-sensitive 
protein modification studies on mitochondrial or insulin signaling were performed based 
on in vitro treatment. How does over-nutrition actually affect it and link to the 
development of IR in an animal or human model in vivo has not been determined and is 
of future directions. 
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Conclusion 
These data demonstrate that a daily mild increase in energy expenditure induced 
by either low intensity exercise or β-GPA treatment sufficiently prevents the increase in 
mEH2O2 and the development of IR induced by HFD, supporting the idea that the 
governance of mEH2O2 is a primary factor regulating insulin sensitivity in skeletal muscle. 
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Figure 3-1. β-GPA and exercise prevent insulin resistance induced by HFD in rats 
without affecting body weight.  
Young male S-D rats fed (7 weeks) with standard chow (Chow group), 60% HFD (HF 
group), HFD plus β-GPA for the final 5 weeks (HF-GPA, 2x200 mg/kg/d, 8:30am & 
5:00pm, 7d/wk, by oral gavage), or HFD plus low intensity treadmill exercise (HF-EX 
group, 15m/min, 0 grade, 2 h/d). To determine if daily treatment with β-GPA or low 
intensity daily treadmill exercise are sufficient to preserve insulin sensitivity in rats 
consuming a HFD, OGTT (2g/ kg whole body mass) were conducted during week 6 in 
the morning following an overnight fast (10h). Rats were studied ~16 hours after the 
final β-GPA or exercise treatment. (A) Serum glucose level from OGTT. (B) Area under 
the curve (AUC) of serum glucose level from OGTT. * p<0.05 vs Chow (C) Serum 
insulin level from OGTT. (D) AUC of serum insulin level from OGTT. * p<0.05 vs 
HF-GPA or HF-EX (E) Insulin Sensitivity Index = 1/(glucose AUC x insulin AUC) from 
OGTT. * p<0.05 vs all other groups. (F) Rats‘ body weight over the treatment duration. 
Mean ± SEM. N=10/ group. one-way ANOVA, Tukey.  
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Figure 3-2. β-GPA treatment attenuated HFD impairment in insulin signaling but also 
activate AMPK pathway.  
To determine the treatment effect on insulin signaling and AMPK pathway, 
phosphorylated/total Akt or AMPK were examined by western blotting. Rats were 
studied ~16 hours after the final β-GPA or exercise treatment at week 7. After either a 
4h fast or 1h after a glucose gavage (2g/ kg body weight) performed after a 3h fast, rats' 
red gastrocnemius were harvested for western blotting. β-GPA treatment attenuated 
HFD impairment in insulin signaling. However, unlike the low intensity exercise group, 
AMPK pathway may be involved in the β-GPA mediated effect in glucose clearance. (A) 
The ratio of phosphorylated (Ser473) and total Akt protein level. * p<0.05 vs no glucose 
challenged condition within the same treatment. # P<0.05 vs Chow in glucose 
challenged condition. (B) The ratio of phosphorylated (Thr172) and total AMPK protein 
level. * P<0.05 vs Chow or HF-EX in no glucose challenge condition. # P<0.05 vs all 
other groups in glucose challenged condition. Mean ± SEM. N=5/ group. Glucose(2) X 
Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-3. No HFD or acute glucose loading caused FAO defect in either skeletal 
muscle or liver of rats.  
To determine if HFD or acute high glucose intake influences FAO rate, 7 weeks treated 
rats were sacrificed after a 4h fast or 1h after a single glucose challenge (2g/ kg body 
weight) performed after a 3h fast. Fresh mix gastrocnemius muscle and liver tissue 
homogenate were obtained for palmitate oxidation rate measurement utilizing 
[1-14C]palmitate. The data indicate no HFD or acute glucose loading caused FAO defect. 
Mean ± SEM. N=5/ group. Glucose(2) X Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-4. Little effect of β-GPA and exercise on mitochondria respiration kinetics in 
response to ADP titration in rats.  
Rats‗ PmFBs mitochondria respiration kinetics in response to ADP titration was 
measured in the presence of 5mM glutamate + 2mM malate. Oligomycin and FCCP 
were added subsequently in the end of the ADP titration protocol. Michaelis-Menten 
enzyme kinetics curve was fitted. Other than the decreased sensitivity (increased Km) 
by β-GPA, little treatment effect on the respiration kinetics was found. (A) The quantified 
kinetics trace. (B) Maximal mitochondria respiration capacity from panel A. (C) 
Mitochondria respiration sensitivity (Km) in response to ADP obtained from 
Michaelis-Menten enzyme kinetics. (D) 10µg/ml Oligomycin-inhibited and 4µM 
FCCP-uncoupled respiration rate. *P<0.05 vs Chow or HF-EX. Mean ± SEM. N=5/ 
group. Glucose(2) X Treatment(4) two-way ANOVA, Bonferroni.  
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Figure 3-5. β-GPA and exercise increase mitochondria respiration capacity in response 
to multiple substrates in rats.  
Rats‗ PmFBs mitochondria respiration capacity was measured in response to sequential 
addition of the following substrates. 1mM malate + 25µM palmitoyl-L-carnitine (M+PC) + 
2mM ADP + 2mM glutamate (+Gluta) + 3mM succinate (+Succ) + 10µg/ml oligomycin 
(+Olg) + 4µM FCCP. The data indicate β-GPA and exercise increase mitochondria 
respiration capacity in response to multiple substrates. # P<0.05 vs Chow. @ P<0.05 vs 
Chow-Glucose. *P<0.05 vs HF-Glucose. x P<0.05 vs HF-EX. Mean ± SEM. N=5/ group. 
Glucose(2) X Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-6. Little effect of β-GPA and exercise on mitochondria respiratory control 
indices of rats.  
Mitochondria respiratory control indices which indicate the quality of mitochondria 
OXPHOS capacity were calculated from ADP titration protocol (Fig. 3-4) or multiple 
substrates protocol (Fig. 3-5). Respiration control ratio (RCR) is the quotient of maximal 
state III to oligomycin-inhibited state IV respiration. Uncoupling control ratio (UCR) is the 
quotient of FCCP-uncoupled respiration to oligomycin-inhibited state IV respiration. 
Andenylate control ratio (ACR) is the quotient of FCCP-uncoupled respiration to 
maximal state III respiration. No treatment effect was found expect that, under glucose 
challenged state in multiple substrate condition, an improvement in both RCR 
(increased) and ACR (decreased) by HFD independent of β-GPA or exercise treatment.  
(A) RCR from ADP titration protocol. (B) UCR from ADP titration protocol. (C) ACR from 
ADP titration protocol. (D) RCR from multiple substrates protocol. * P<0.05 vs all other 
groups in glucose challenged condition. (E) UCR from multiple substrates protocol. (F) 
ACR from multiple substrates protocol. * P<0.05 vs Chow in no glucose challenge 
condition. # P<0.05 vs Chow in glucose challenged condition. Mean ± SEM. N=5/ group. 
Glucose(2) X Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-7. β-GPA and exercise attenuated HFD caused mEH2O2 challenged by complex 
I reverse electron flux in rats.  
To determine if high caloric intake acutely and chronically influences mEH2O2, 7 week 
treated rats were sacrificed after a 4h fast or 1h after a single glucose challenge (2g/ kg 
body weight) performed after a 3h fast. The kinetics of PmFBs state IV mEH2O2 in 
response to succinate titration was measured in the presence of 5µM glutamate + 2µM 
malate. Michaelis-Menten enzyme kinetics curve was fitted. The results indicate β-GPA 
and exercise attenuated HFD caused mEH2O2. Further, mEH2O2 are remarkably sensitive 
to acute high glucose intake. (A) The kinetics response. (B) Maximal mEH2O2 (at 3mM 
succinate) from panel A. * P<0.05 vs Chow or HF-GPA. p=.0806 main factor effect with 
vs without glucose challenge. Note that a single glucose challenge on chow diet fed rats 
1h before sacrifice increase 64% of mEH2O2 although it does not reach statistical 
significance. (C) mEH2O2 sensitivity (Km) in response to succinate titration obtained from 
Michaelis-Menten enzyme kinetics. Mean ± SEM. N=5/ group. Glucose(2) X 
Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-8. β-GPA and exercise attenuated HFD caused mEH2O2 challenged by multiple 
substrates in rats. 
Rats‗ PmFBs state IV mEH2O2 in oxidizing 25µM palmitoyl-L-carnitine + 1mM malate + 
2mM glutamate (PCMG), + 3mM succinate (+Succ), and + 10mM Glycerol-3-Phosphate 
(+G3P). The result indicate both β-GPA and exercise treatment sufficiently normalize 
the HFD caused mEH2O2 under multiple substrate conditions. Note that a single glucose 
challenge (2g/ kg body weight) on chow diet fed rats 1h before sacrifice increase 
30-108% of mEH2O2 * P<0.05 vs HF in each substrate condition either with or without 
glucose challenge. Mean ± SEM. N=5/ group. Glucose(2) X Treatment(4) two-way 
ANOVA, Bonferroni. 
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Figure 3-9. β-GPA and exercise attenuated HFD caused mitochondria mFRL% in rats. 
Mitochondrial mFRL% was calculated from H2O2 generated per O2 consumed. H2O2 
generation (Fig. 3-8) and O2 consumption (Fig. 3-5) were under the condition 
mitochondria oxidizing 25µM palmitoyl-L-carnitine + 1mM malate + 2mM glutamate + 
3mM succinate in state IV (with oligomycin). * P<0.05 vs HF-EX. # P<0.05 vs Chow or 
HF. Mean ± SEM. N=5/ group. Glucose(2) X Treatment(4) two-way ANOVA, Bonferroni. 
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Figure 3-10. AMPKα2 genotype did not affect the β-GPA effect on body composition, 
metabolic state and locomotor activity in mice.  
To determine if AMPKα2 genotype influences the β-GPA effects on metabolism, 
AMPKα2-DN mice and its WT littermates were monitored for two complete light-dark 
cycles (48h) via an indirect calorimetry system after 4 days of acclimation during week 8 
of diet treatment. Body composition was determined right after the calorimetry system 
using the Echo Magnetic Resonance Imaging system. The data of metabolic state had a 
very similar trend when normalized to either lean body mass (shown) or whole body 
mass. Regardless of the AMPKα2 genotype, β-GPA treatment increases energy 
expenditure without affecting locomotor activity, and prevents HF-induced body weight 
gain despite higher food intake. (A) Body weight over the 10 weeks of diet treatment. * 
P<0.05 vs Chow, WT-HF-GPA or DN-HF-GPA. (B) Body composition. # P<0.05 vs 
Chow, WT-HF-GPA or DN-HF-GPA in lean body mass. * P<0.05 vs Chow, WT-HF-GPA 
or DN-HF-GPA in fat body mass. The total body mass percentage of lean or fat was 
indicated. (C) Food intake (48h total). * P<0.05 vs WT-Chow, WT-HF or DN-HF. (D) 
Energy expenditure rate (48h average). * P<0.05 vs WT-Chow, WT-HF or DN-HF. (E) 
Oxygen consumption rate (48h average). * P<0.05 vs WT-Chow, WT-HF or DN-HF. (F) 
RER (48h average). * P<0.05 vs WT-Chow. # P<0.05 vs WT-HF or DN-HF. (G) 
Locomotor activity (sum of X, Y, Z axis count/activity, 48h total). * P<0.05 vs WT-Chow. 
Mean ± SEM. N=9~18/ group. One-way ANOVA + Tukey. 
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Figure 3-11. β-GPA prevented HFD caused IR regardless of the AMPKα2 genotype in 
mice. 
To determine if mice AMPKα2 genotype affect the effects of β-GPA on insulin sensitivity 
after HFD, IPGTT (1.5g/ kg body weight) was conducted in the morning following a 4h 
fasting in mice at week 9 of treatment. Plasma for [insulin] measurement was collected 
from the tail vein in the basal state and 30min after the glucose injection. Mice were 
further sacrificed in the morning following a 4h fasting at week 10 of treatment. Soleus 
(slow twitch) and EDL (fast twitch) muscle were harvested for in vitro determination of 
muscle 3+H-2-DOG uptake. Mice were studied ~16 hours after the last β-GPA treatment 
in both IPGTT and 3+H-2-DOG uptake experiments. The data indicate there was no 
AMPKα2 genotype effect. (A) [Glucose] from IPGTT. (B) Area under the curve (AUC) of 
[Glucose] from IPGTT. * P<0.05 vs WT-Chow, WT-HF-GPA or DN-HF-GPA. (C) [Insulin] 
from baseline and 30 min after glucose injection. * P<0.05 vs WT-Chow, WT-HF-GPA or 
DN-HF-GPA. (D) Muscle 3+H-2-DOG uptake. * P<0.05 vs WT-Chow or DN-HF. # 
P<0.05 vs WT-Chow or WT-HF-GPA. ∆ P<0.05 vs all other groups. ᶱ P<0.05 vs DN-HF. 
+ P<0.05 vs all other groups but not the other HF without GPA treated group. $ P<0.05 
vs all other groups but not the other GPA treated group. Mean ± SEM. N=9~18/ group. 
One-way ANOVA + Tukey. 
 
 - 96 - 
 
 
 
 - 97 - 
 
Figure 3-12. β-GPA prevented the HFD caused mEH2O2 and mFRL% regardless of 
AMPKα2 genotype in mice. 
To determine if AMPKα2 genotype affect the β-GPA treatment effect in mitochondrial 
respiration and state IV mEH2O2 of HFD fed mice, assays were performed in PmFBs 
prepared from 4h fasted AMPKα2-DN mice and its wild type littermates after 10 weeks 
of HFD feeding. The data indicated, without affecting mitochondria respiration capacity, 
β-GPA prevents the HFD-induced increase in mEH2O2 and mFRL% regardless of 
AMPKα2 genotype. (A) Muscle mEH2O2 in response to 1mM malate + 25µM 
palmitoyl-L-carnitine (M+PC) + 2mM glutamate (+Gluta), + 9mM succinate (+Succ), and 
+ 10mM Glycerol-3-Phosphate (+G3P). * P<0.05 vs W-Chow, WT-HF-GPA or 
DN-HF-GPA. # P<0.05 vs WT-HF-GPA or DN-HF-GPA. + P<0.05 vs WT-HF-GPA. (B) 
Muscle mEH2O2 in response to 9mM succinate. # P<0.05 vs WT-HF or DN-HF. * P<0.05 
vs WT-Chow. (C) mFRL% was calculated from H2O2 generated per O2 consumed. H2O2 
generation (panel A) and O2 consumption (panel D) were under the condition 
mitochondria oxidizing M+PC+Gluta+Succ under state IV condition (with oligomycin). * 
P<0.05 vs WT-Chow, WT-HF-GPA or DN-HF-GPA. # P<0.05 vs WT-HF-GPA or 
DN-HF-GPA. + P<0.05 vs WT-Chow. (D) Muscle mitochondria respiration capacity in 
response to 1mM malate + 25µM palmitoyl-L-carnitine (M+PC) + 2mM ADP + 2mM 
glutamate (Gluta) + 9mM succinate (Succ) + 10µg/ml oligomycin (Oligo) + 4µM FCCP. 
Mean ± SEM. N=9~18/ group. One-way ANOVA + Tukey. 
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Figure 3-13. No clear HFD, β-GPA or AMPKα2 genotype effect on mitochondria 
respiratory control indices of mice.  
Mitochondria respiratory control indices (as explained in figure 3-6) were calculated 
from mitochondrial respiration capacity (Fig. 3-12 (D)). Overall, no treatment or 
genotype effect was found indicating no mitochondrial OXPHOS defect. (A) RCR. (B) 
UCR. * P<0.05 vs WT-HF. (C) ACR. Mean ± SEM. N=9~18/ group. One-way ANOVA + 
Tukey. 
  
 
 
CHAPTER 4: Integrated Discussion 
 
The roles of mitochondrial FAO/OXPHOS capacity and oxidative stress in the 
development of diabetes have recently gained considerable attention, and more 
specifically how insulin action is regulated in skeletal muscle (the main glucose disposal 
organ). In Chapter 1, review of the literature suggests a causative role of mitochondrial 
oxidative stress in the etiology of diet induced IR. It has been demonstrated that acute 
and chronic nutritional oversupply increases skeletal muscle mEH2O2, a phenomenon that 
is causally linked to IR64. Whole body metabolic imbalance is the underlying cause of 
metabolic diseases, and within cells metabolic balance is a function of how well 
substrate supply matches energy demand and vice versa. The interplay between 
metabolic supply and ROS production is well established, yet the extent to which energy 
expenditure can compensate for the deleterious effects of over-nutrition on ROS 
production, cellular redox state and insulin sensitivity is currently unknown. The studies 
described in chapter 2 and 3 were all conducted with hypotheses governed by the same 
theme: to examine the impact of a mild increase in energy expenditure on over-nutrition 
induced skeletal muscle mitochondrial oxidative stress and IR. 
In chapter 2, an acute effect of metabolic oversupply (lipid loading) and energy 
expenditure (low intensity exercise) on the regulation of rat skeletal muscle 
mitochondria was examined. This study examed mEH2O2, ΔΨm and mCa
2+
RC under state 
IV and more physiological state III respiration conditions using a novel ―clamp‖ 
technique. These data revealed a number of important findings. First, without affecting 
OXPHOS capacity, skeletal muscle mEH2O2, ΔΨm and mCa
2+
RC were extremely 
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sensitive to metabolic status. The lipid overloading of ~12% of the daily total caloric 
intake (when in HFD conditions) acutely caused an adverse effect of these 3 
parameters of mitochondria while post-meal low intensity exercise nearly completely 
attenuated the response. This supports the idea that mitochondrial mEH2O2 emission is 
more likely the preceding and possibly primary underlying cause of IR. OXPHOS 
capacity, on the other hand, may play a secondary role. Furthermore, it is notable that 
low intensity exercise is sufficient to attenuate the acute lipid loading induced defects on 
mEH2O2, ΔΨm and mCa
2+
RC. It follows the principle of bioenergetics that a reduction in 
ΔΨm by mildly increasing energy demand and therefore JO2 from idling (close to state 
IV) can significantly reduce ―the reducing pressure of electron transport system (ETS)‖ 
and oxidant production.  
In chapter 3, the impact of a mild daily increase in energy expenditure on mEH2O2 
and the development of insulin resistance were examined in the context of chronic HF 
intake. The findings of this study provide further support for a causative role of 
mitochondrial H2O2 emission in the development of diet induced IR. This study again 
shows that a long term HFD causes an increased skeletal muscle mEH2O2, albeit state IV 
data only, in conjunction with the development of IR in rodents. Mildly increased energy 
expenditure by either exercise or β-GPA attenuated HFD caused both mEH2O2 elevation 
and IR development. The treatment effects of HFD, exercise or β-GPA appeared to be 
mitochondrial density, respiratory function, fatty acid oxidation rate and AMPKα2 
genotype independent, leaving the reduction in mitochondrial oxidative stress as the 
most likely primary mechanism of exercise and β-GPA on attenuating HFD caused IR. 
In the context of both acute and chronic manipulation of positive (oversupply) and 
negative (expenditure) cellular energy balance, together, these findings support the 
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mounting evidence favoring the causative role of skeletal muscle mitochondrial H2O2 
emission/oxidative stress in the development of diet induced IR. These data 
demonstrated a mild increase in energy expenditure can sufficiently attenuate the HFD 
caused oxidative stress and IR. This is important because it not only supports the 
causative role of oxidative stress based on the known inverse exponential relationship 
of superoxide production and JO2 under low respiration condition, but also provides a 
clinical and practical strategy (i.e., mild physical activity) to treat/prevent over-nutrition 
caused IR. These findings also provide evidence that mitochondrial oxidative stress 
and related effects are very sensitive and dynamically regulated by the metabolic status. 
ΔΨm and oxidative stress are likely among the preceding factors acutely elevated by 
lipid loading and ultimately could lead to the development of IR and mitochondrial 
dysfunction (reduced density and respiration capacity). A shift in respiratory activity from 
idling to mild increase in state III respiration is sufficient to prevent/attenuate the oxidant 
production and related risks. 
Given that the literature and the presenting data favor the causative role of 
mitochondrial oxidant production in the etiology of diet induced IR, the molecular 
mechanism of how mitochondrial H2O2 causes IR is still largely unknown and is of 
important direction of future studies. Redox-sensitive protein modifications may be a 
crucial mechanism of how oxidative stress regulates the insulin signaling cascade and 
causes IR. The reversible prosperity of redox-sensitive protein modifications may 
therefore allow increased energy expenditure (reduced oxidative stress) to dynamically 
compensate for the metabolic oversupply caused IR. 
In the present studies, the potential influence of DAG-PKC-IRS pathway was not 
examined. Intracellular accumulation of DAG due to mitochondrial dysfunction has been 
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widely suggested as a primary cause of insulin resistance in skeletal muscle280. In the 
present study, HFD induced insulin resistance did not affect mitochondrial OXPHOS or 
content. Moreover, the improvements in insulin sensitivity found in HFD animals that 
were subjected to exercise or β-GPA treatment occurred in the absence of any change 
in ―mitochondrial function‖. It is certainly possible that cytosolic lipid levels, and thus 
activity of DAG-induced signaling, decreased in the muscle of exercise and β-GPA 
treated animals due to the increase in energy demand. This would be entirely consistent 
with our hypothesis that the metabolic defect induced by a HFD is triggered by the 
imbalance in energy supply relative to demand and that increasing energy demand 
relieves this imbalance. Although the exercise and β-GPA treatment effect on mEH2O2 
and IR is clear and supports our hypothesis that mEH2O2 is a key factor regulating insulin 
sensitivity, we cannot exclude the potential influence of the DAG-PKC-IRS pathway. 
However, arguing against a primary role for DAG-PKC-IRS pathway is the study by 
Finck et al281 who found that muscle lipid accumulation was completely dissociated from 
muscle insulin sensitivity in transgenic mice with targeted PPARα knockout or 
overexpression. Nevertheless, whether the DAG-PKC-IRS pathway or ROS are the 
more dominate primary factor leading to the over-nutrition caused IR is still unknown, 
our data support the idea that the ROS-mediated effect is a primary factor controling 
insulin sensitivity in skeletal muscle. 
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